CASEID,PRIMARYID,CASEVERSION,I_F_CODE,EVENT_DT,MFR_DT,INIT_FDA_DT,FDA_DT,REPT_COD,AUTH_NUM,MFR_NUM,MFR_SNDR,LIT_REF,AGE,AGE_COD,AGE_GRP,SEX,E_SUB,WT,WT_COD,REPT_DT,TO_MFR,OCCP_COD,REPORTER_COUNTRY,OCCR_COUNTRY,DRUGNAME,PT,PRIMARYID_OUTC,OUTC_COD,PRIMARYID_RPSR,RPSR_COD,PRIMARYID_THER,DSG_DRUG_SEQ,START_DT,END_DT,DUR,DUR_COD,PRIMARYID_INDI,INDI_DRUG_SEQ,INDI_PT
10155701,101557015,5,F,20140103,20160822,20140506,20160826,EXP,,UG-GILEAD-2014-0101523,GILEAD,,41,YR,A,M,Y,73,KG,20160826,,OT,UG,UG,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Acute kidney injury;Anaemia;Bacteraemia;Kaposi's sarcoma;Urinary tract infection,101557015,OT,,,101557015,1,20130724,20140423,,,101557015,1,HIV infection
10167630,101676302,2,F,,20160719,20140512,20160719,EXP,,KH-BRISTOL-MYERS SQUIBB COMPANY-20721353,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160719,,CN,US,KH,EFAVIRENZ,Delirium,101676302,LT,,,,,,,,,101676302,1,HIV infection
10167631,101676312,2,F,,20160712,20140512,20160715,EXP,,KH-BRISTOL-MYERS SQUIBB COMPANY-20721361,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160715,,CN,US,KH,EFAVIRENZ,Insomnia,101676312,DS,,,,,,,,,101676312,1,HIV infection
10167637,101676372,2,F,,20160712,20140512,20160715,EXP,,KH-BRISTOL-MYERS SQUIBB COMPANY-20721379,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160715,,CN,US,KH,EFAVIRENZ,Skin disorder,101676372,LT,,,,,,,,,101676372,1,HIV infection
10168636,101686363,3,F,,20160817,20140513,20160822,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-20727152,BRISTOL MYERS SQUIBB,,1,DY,,,Y,,,20160822,,OT,FR,FR,EFAVIRENZ,Foetal exposure during pregnancy;Pachygyria,101686363,OT,,,,,,,,,101686363,1,Product used for unknown indication
10168639,101686392,2,F,,20160719,20140513,20160719,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-20704490,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160719,,CN,US,FR,EFAVIRENZ,Cerebral ventricle dilatation;Foetal exposure during pregnancy;White matter lesion,101686392,OT,,,,,,,,,101686392,1,Product used for unknown indication
10168640,101686403,3,F,,20160826,20140513,20160901,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-20727178,BRISTOL MYERS SQUIBB,,,,I,,Y,,,20160901,,CN,US,FR,EFAVIRENZ,Congenital central nervous system anomaly;Foetal exposure during pregnancy,101686403,CA,,,,,,,,,101686403,1,Product used for unknown indication
10168641,101686412,2,F,,20160718,20140513,20160718,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-20727186,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160718,,OT,FR,FR,EFAVIRENZ,Cerebral cyst;Foetal exposure during pregnancy,101686412,OT,,,,,,,,,101686412,1,Product used for unknown indication
10190829,101908294,4,F,,20160713,20140523,20160715,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-20810222,BRISTOL MYERS SQUIBB,,1,DY,,M,Y,1.3,KG,20160715,,OT,ZA,ZA,EFAVIRENZ,Drug withdrawal syndrome neonatal;Endotracheal intubation;Exposure during breast feeding;Foetal exposure during pregnancy;Generalised tonic-clonic seizure;Off label use,101908294,LT,,,,,,,,,101908294,1,Product used for unknown indication
10190830,101908304,4,F,,20160712,20140523,20160715,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-20782470,BRISTOL MYERS SQUIBB,,1,DY,,F,Y,2.17,KG,20160715,,OT,ZA,ZA,EFAVIRENZ,Drug withdrawal syndrome neonatal;Exposure during breast feeding;Foetal exposure during pregnancy;Off label use,101908304,HO,,,,,,,,,101908304,1,Product used for unknown indication
10242769,102427692,2,F,,20160712,20140617,20160715,EXP,,NG-BRISTOL-MYERS SQUIBB COMPANY-20782553,BRISTOL MYERS SQUIBB,,1,DEC,,,Y,,,20160715,,CN,US,NG,EFAVIRENZ,Drug interaction,102427692,OT,,,,,,,,,102427692,1,HIV infection
10250545,102505453,3,F,,20160714,20140620,20160714,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-20979142,BRISTOL MYERS SQUIBB,,36,YR,,M,Y,,,20160714,,CN,US,PT,EFAVIRENZ,Gastrointestinal disorder;Neurotoxicity;Skin disorder,102505453,OT,,,102505453,1,2007,,,,102505453,1,HIV infection
10376122,103761225,5,F,,20160822,20140811,20160823,EXP,,MW-BRISTOL-MYERS SQUIBB COMPANY-21278197,BRISTOL MYERS SQUIBB,,,,,M,Y,1.7,KG,20160823,,CN,US,MW,EFAVIRENZ,Accessory auricle;Foetal exposure during pregnancy;Premature baby,103761225,CA,,,103761225,1,20120426,20140410,,,103761225,1,Product used for unknown indication
10377280,103772805,5,F,20060512,20160706,20140812,20160712,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-14021034,BRISTOL MYERS SQUIBB,,45,YR,,F,Y,,,20160712,,MD,JP,JP,EFAVIRENZ,Blood glucose increased;Hypercholesterolaemia;Nephrolithiasis,103772805,OT,,,103772805,1,20060125,20120523,,,103772805,1,HIV infection
10457439,104574392,2,F,,20160713,20140916,20160715,EXP,,CM-BRISTOL-MYERS SQUIBB COMPANY-21389077,BRISTOL MYERS SQUIBB,,30,YR,,M,Y,,,20160715,,OT,AU,CM,EFAVIRENZ,Paradoxical drug reaction,104574392,HO,,,104574392,1,20130119,,,,104574392,1,HIV infection
10487575,104875752,2,F,,20160718,20141001,20160718,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-21423868,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160718,,CN,ZA,ZA,EFAVIRENZ,Completed suicide;Nervous system disorder,104875752,OT,,,,,,,,,104875752,1,HIV infection
10495703,104957032,2,F,,20160718,20141003,20160718,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-21429014,BRISTOL MYERS SQUIBB,,41,YR,,M,Y,,,20160718,,CN,CA,CA,SUSTIVA,Drug interaction;Virologic failure,104957032,OT,,,,,,,,,104957032,1,HIV infection
10531209,105312092,2,F,,20160714,20141021,20160715,EXP,,MW-BRISTOL-MYERS SQUIBB COMPANY-21505896,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20160715,,OT,MW,MW,EFAVIRENZ,Neuropathy peripheral;Osteonecrosis,105312092,OT,,,,,,,,,105312092,1,HIV infection
10750185,107501853,3,F,20140103,20160822,20150129,20160830,EXP,,UG-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-004640,BRISTOL MYERS SQUIBB,,41,YR,,M,Y,73,KG,20160830,,OT,UG,UG,"EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",Acute kidney injury;Anaemia;Bacteraemia;Disease progression;Urinary tract infection,107501853,OT,,,107501853,1,20130725,20131106,,,107501853,1,Antiretroviral therapy
11022204,110222043,3,F,20131030,20160905,20150413,20160913,EXP,ZA-ANRS-201500264,ZA-GILEAD-2015-0147988,GILEAD,,42,YR,A,M,Y,56.7,KG,20160913,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Anaemia;Gamma-glutamyltransferase increased;Hypokalaemia;Renal failure,110222043,DE,,,110222043,1,20130405,,,,110222043,1,HIV infection
11114820,111148202,2,F,,20160720,20150515,20160720,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-029333,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160720,,OT,US,US,EFAVIRENZ,Drug interaction;Medication error,,,,,,,,,,,111148202,1,Antiretroviral therapy
11123776,111237762,2,F,,20160720,20150519,20160723,PER,,US-009507513-1505USA007383,MERCK,,,,,,Y,,,20160723,,CN,US,US,EFAVIRENZ,Drug interaction;Medication error,,,,,,,,,,,111237762,1,Antiretroviral therapy
11200116,1120011610,10,F,20141021,20160701,20150618,20160711,EXP,,US-BMSGILMSD-2015-0158849,GILEAD,,0,YR,N,M,Y,1.36,KG,20160711,,MD,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Congenital hydronephrosis;Foetal exposure during pregnancy;Foetal megacystis;Pulmonary embolism;Pulmonary haemorrhage,1120011610,CA,,,1120011610,1,20141021,20150611,,,1120011610,1,HIV infection
11202620,112026203,3,F,,20160715,20150619,20160715,EXP,,TN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-037940,BRISTOL MYERS SQUIBB,,37,YR,,M,Y,,,20160715,,OT,TN,TN,EFAVIRENZ,Acute coronary syndrome,112026203,OT,,,112026203,1,2008,,,,112026203,1,HIV infection
11202890,112028904,4,F,,20160816,20150619,20160822,EXP,,TN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-040845,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160822,,OT,TN,TN,EFAVIRENZ,Acute coronary syndrome,112028904,OT,,,,,,,,,112028904,1,HIV infection
11307801,113078018,8,F,,20160919,20150724,20160929,EXP,,DE-ROCHE-1495718,ROCHE,", PETERSEN J, HERZER K, FERENCI P, GSCHWANTLER M, WEDEMEYER H, BERG T, SPENGLER U, WEILAND O, VAN DER VALK M, ROCKSTROH J, PECK-RADOSAVLJEVIC M, ZHAO Y, JIMENEZ-EXPOSITO M AND ZEUZEM S. DACLATASVIR PLUS SOFOSBUVIR, WITH OR WITHOUT RIBAVIRIN, ACHIEVED HIGH SUSTAINED VIROLOGICAL RESPONSE RATES IN PATIENTS WITH HCV INFECTION AND ADVANCED LIVER DISEASE IN A REAL-WORLD COHORT. GUT 2016 SEP 07;:1-10.",,,,,Y,,,20160929,,MD,DE,DE,EFAVIRENZ,Abdominal pain;Acute kidney injury;Anaemia;Anal cancer;Arthralgia;Calculus urinary;Circulatory collapse;Clostridium difficile colitis;Dehydration;Diarrhoea;Drug withdrawal syndrome;Dyspnoea;Erysipelas;Fatigue;Fluid overload;Gastrointestinal infection;General physical health deterioration;Haemorrhoidal haemorrhage;Headache;Hepatic encephalopathy;Hepatic failure;Hepatocellular carcinoma;Hypersensitivity vasculitis;Hypertension;Hyponatraemia;Infection;Lactic acidosis;Liver disorder;Lymphoedema;Multiple organ dysfunction syndrome;Myocardial infarction;Nausea;Neutropenia;Pancreatitis acute;Pancytopenia;Peritonitis bacterial;Portal vein thrombosis;Soft tissue infection;Somnolence;Streptococcal sepsis;Vertigo,113078018,DE,,,,,,,,,113078018,1,Chronic hepatitis C
11348844,113488443,3,F,20141105,20160701,20150806,20160713,EXP,,HT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051188,BRISTOL MYERS SQUIBB,,30,YR,,F,Y,,,20160713,,OT,HT,HT,EFAVIRENZ,Abortion spontaneous;Maternal exposure during pregnancy,113488443,OT,,,113488443,1,20140918,20140922,,,113488443,1,HIV infection
11460939,114609393,3,F,20150411,20160621,20150904,20160704,EXP,,TH-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-057252,BRISTOL MYERS SQUIBB,,30,YR,,F,Y,,,20160704,,OT,TH,TH,EFAVIRENZ,Abortion spontaneous;Maternal exposure during pregnancy;Off label use,114609393,OT,,,114609393,1,20140604,,,,114609393,1,HIV infection
11629566,116295663,3,F,20150217,20160905,20151014,20160908,EXP,,ZA-009507513-1510ZAF006032,MERCK,,66,YR,,M,Y,60.1,KG,20160908,,MD,ZA,ZA,EFAVIRENZ (+) EMTRICITABINE (+) TENOFOVIR DISOPROXIL FUMARATE,Acute kidney injury;Cardiac failure congestive;Hypernatraemia,116295663,HO,,,116295663,1,20150211,20150224,,,116295663,1,HIV infection
11633134,116331344,4,F,20150217,20160905,20151015,20160909,EXP,,ZA-GILEAD-2015-0176579,GILEAD,,66,YR,E,M,Y,60,KG,20160909,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Acute kidney injury;Cardiac failure congestive;Hypernatraemia;Renal impairment,116331344,DE,,,116331344,1,20150211,20150302,,,116331344,1,HIV infection
11641525,116415256,6,F,20150409,20160905,20151019,20160913,EXP,,ZA-GILEAD-2015-0176566,GILEAD,,35,YR,A,F,Y,69.5,KG,20160913,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Acute kidney injury;Delirium;Gastroenteritis,116415256,OT,,,116415256,1,20141007,,,,116415256,1,HIV infection
11641566,116415662,2,F,20150926,20160905,20151019,20160913,EXP,,ZA-GILEAD-2015-0177198,GILEAD,,62,YR,A,M,Y,42.6,KG,20160913,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Death,116415662,OT,,,116415662,1,20150612,,,,116415662,1,HIV infection
11684968,116849682,2,F,20000609,20160825,20151030,20160825,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-15158538,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160825,,OT,US,US,EFAVIRENZ,Live birth;Maternal exposure during pregnancy,,,,,,,,,,,116849682,1,HIV infection
11691124,116911243,3,F,20100722,20160819,20151102,20160823,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-15467632,BRISTOL MYERS SQUIBB,,30,YR,,F,Y,,,20160823,,CN,US,US,"EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",Maternal exposure during pregnancy;Stillbirth,116911243,OT,,,,,,,,,116911243,1,Antiretroviral therapy
11695440,116954403,3,F,20110910,20160912,20151104,20160912,EXP,,TH-BRISTOL-MYERS SQUIBB COMPANY-16191124,BRISTOL MYERS SQUIBB,,0,DY,,F,Y,,,20160912,,CN,GB,TH,EFAVIRENZ,Foetal exposure during pregnancy;Jaundice neonatal;Premature baby,116954403,HO,,,116954403,1,,20110214,,,116954403,1,Product used for unknown indication
11697343,116973432,2,F,,20160822,20151104,20160823,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-15467640,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160823,,CN,US,US,"EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",Foetal exposure during pregnancy;Foetal growth restriction;Wolf-Hirschhorn syndrome,116973432,CA,,,,,,,,,116973432,1,Product used for unknown indication
11699314,116993142,2,F,20110910,20160819,20151104,20160819,EXP,,TH-BRISTOL-MYERS SQUIBB COMPANY-16170078,BRISTOL MYERS SQUIBB,,35,YR,,F,Y,55,KG,20160819,,CN,GB,TH,EFAVIRENZ,Abortion threatened;Caesarean section;Live birth;Maternal exposure during pregnancy;Pregnancy on contraceptive;Premature delivery;Premature rupture of membranes,116993142,OT,,,116993142,1,20101104,20110214,,,116993142,1,HIV infection
11703722,117037222,2,F,20080920,20160131,20151106,20160701,EXP,,UG-BRISTOL-MYERS SQUIBB COMPANY-14902597,BRISTOL MYERS SQUIBB,,35,YR,,F,Y,,,20160701,,OT,UG,UG,EFAVIRENZ,Abortion induced;Maternal exposure during pregnancy,117037222,OT,,,117037222,1,20070503,20080721,,,117037222,1,Antiretroviral therapy
11703758,117037582,2,F,20040514,20160824,20151106,20160824,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-15152010,BRISTOL MYERS SQUIBB,,38,YR,,F,Y,,,20160824,,CN,US,FR,EFAVIRENZ,Amniotic fluid volume increased;Live birth;Maternal exposure during pregnancy;Premature delivery,117037582,OT,,,117037582,1,20010401,20040102,,,117037582,1,Antiretroviral therapy
11705544,117055442,2,F,,20160819,20151106,20160819,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2008-000009,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160819,,MD,FR,FR,SUSTIVA,Foetal exposure during pregnancy;Renal dysplasia;Urinary tract obstruction,117055442,CA,,,117055442,1,20070217,20070703,,,117055442,1,Product used for unknown indication
11708758,117087582,2,F,20100406,20160822,20151107,20160822,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-15323637,BRISTOL MYERS SQUIBB,,0,DY,,F,Y,1.69,KG,20160822,,OT,FR,FR,SUSTIVA,Cardiomegaly;Congenital pulmonary valve atresia;Congenital tricuspid valve atresia;Foetal exposure during pregnancy;Neonatal respiratory distress syndrome;Premature baby;Ventricular hypoplasia,117087582,CA,,,117087582,1,20091119,20100406,,,117087582,1,Product used for unknown indication
11708763,117087632,2,F,20100406,20160822,20151107,20160822,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-15323611,BRISTOL MYERS SQUIBB,,31,YR,,F,Y,,,20160822,,OT,FR,FR,SUSTIVA,Albuminuria;Anaemia;Blood alkaline phosphatase increased;Blood urea decreased;Live birth;Maternal exposure during pregnancy;Premature delivery;Proteinuria;Uterine disorder,117087632,OT,,,117087632,1,20091119,20091001,,,117087632,1,Antiretroviral therapy
11709326,117093265,5,F,,20160701,20151107,20160712,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-073574,BRISTOL MYERS SQUIBB,,1,DY,,,Y,,,20160712,,OT,ES,ES,EFAVIRENZ,Foetal exposure during pregnancy;Polydactyly,117093265,CA,,,,,,,,,117093265,1,Product used for unknown indication
11712975,117129752,2,F,20120627,20160825,20151108,20160826,EXP,,MW-BRISTOL-MYERS SQUIBB COMPANY-17468729,BRISTOL MYERS SQUIBB,,0,DY,,F,Y,3.6,KG,20160826,,OT,MW,MW,SUSTIVA,Congenital acrochordon;Foetal exposure during pregnancy;Premature baby;Sepsis neonatal,117129752,CA,,,117129752,1,20100222,20111114,,,117129752,1,Product used for unknown indication
11713022,117130223,3,F,20080807,20160621,20151108,20160703,EXP,,ZW-BRISTOL-MYERS SQUIBB COMPANY-14902563,BRISTOL MYERS SQUIBB,,36,YR,,F,Y,,,20160703,,OT,ZW,ZW,EFAVIRENZ,Abortion spontaneous;Maternal exposure during pregnancy,117130223,OT,,,117130223,1,20041228,,,,117130223,1,Antiretroviral therapy
11717175,117171752,2,F,20001024,20160826,20151109,20160826,EXP,,BE-BRISTOL-MYERS SQUIBB COMPANY-2001SUS0512,BRISTOL MYERS SQUIBB,,,,,,Y,.19,KG,20160826,,MD,BE,BE,SUSTIVA,Foetal exposure during pregnancy;Foetal growth restriction;Placental disorder,117171752,CA,,,,,,,,,117171752,1,Product used for unknown indication
11726897,117268972,2,F,20000520,20160826,20151112,20160826,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-2000SUS0652,BRISTOL MYERS SQUIBB,,35,YR,,F,Y,61,KG,20160826,,CN,FR,FR,SUSTIVA,Abdominal distension;Anogenital warts;Caesarean section;Live birth;Pregnancy,117268972,HO,,,117268972,1,20000627,20000627,,,117268972,1,HIV infection
11731187,117311873,3,F,,20160826,20151112,20160826,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2001SUS0064,BRISTOL MYERS SQUIBB,,1,DY,,,Y,2.58,KG,20160826,,OT,DE,DE,SUSTIVA,Atrial septal defect;Foetal exposure during pregnancy;Patent ductus arteriosus;Ventricular septal defect,117311873,CA,,,,,,,,,117311873,1,Product used for unknown indication
11734511,117345112,2,F,20100406,20160822,20151113,20160830,EXP,,FR-009507513-1010USA01114B1,MERCK,,1,DY,,F,Y,1.69,KG,20160830,,CN,US,FR,SUSTIVA,Cardiomegaly;Congenital pulmonary valve atresia;Congenital tricuspid valve atresia;Foetal exposure during pregnancy;Neonatal respiratory distress syndrome;Premature baby;Ventricular hypoplasia,117345112,CA,,,117345112,1,20091119,20091001,,,117345112,1,Product used for unknown indication
11739293,117392932,2,F,2008,20160824,20151113,20160824,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-14652952,BRISTOL MYERS SQUIBB,,36,YR,,F,Y,,,20160824,,OT,ZA,ZA,EFAVIRENZ,Caesarean section;Maternal exposure during pregnancy;Stillbirth,117392932,OT,,,117392932,1,20060201,,,,117392932,1,HIV infection
11739603,117396032,2,F,20090315,20160131,20151113,20160804,EXP,,UG-BRISTOL-MYERS SQUIBB COMPANY-14902605,BRISTOL MYERS SQUIBB,,27,YR,,F,Y,,,20160804,,OT,UG,UG,EFAVIRENZ,Abortion spontaneous;Maternal exposure during pregnancy,117396032,OT,,,117396032,1,20060206,20081212,,,117396032,1,Antiretroviral therapy
11739719,117397192,2,F,20110910,20160819,20151113,20160826,EXP,,TH-ABBVIE-11P-155-0866544-00,ABBVIE,,35,YR,,F,Y,55,KG,20160826,,MD,COUNTRY NOT SPECIFIED,TH,EFAVIRENZ,Abortion threatened;Caesarean section;Live birth;Pregnancy;Pregnancy on contraceptive;Premature delivery;Premature rupture of membranes,117397192,OT,,,117397192,1,20101104,20110214,,,117397192,1,HIV infection
11739738,117397382,2,F,20090519,20160824,20151113,20160824,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-14654230,BRISTOL MYERS SQUIBB,,,,N,M,Y,1.54,KG,20160824,,OT,ZA,ZA,EFAVIRENZ,Foetal exposure during pregnancy;Neonatal asphyxia,117397382,OT,,,117397382,1,,20090519,,,117397382,1,Product used for unknown indication
11741281,117412812,2,F,,20160913,20151116,20160914,EXP,,CA-ROCHE-1659874,ROCHE,,54,YR,,M,Y,,,20160914,,OT,CA,CA,SUSTIVA,Depression;Drug interaction,117412812,OT,,,,,,,,,117412812,1,Product used for unknown indication
11762836,117628362,2,F,20110820,20160825,20151120,20160825,EXP,,IN-BRISTOL-MYERS SQUIBB COMPANY-17379041,BRISTOL MYERS SQUIBB,,28,YR,,F,Y,71,KG,20160825,,OT,IN,IN,EFAVIRENZ,Abortion induced;Maternal exposure during pregnancy,117628362,OT,,,117628362,1,20110805,20110805,,,117628362,1,HIV infection
11762838,117628383,3,F,20130411,20160825,20151120,20160825,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-18861518,BRISTOL MYERS SQUIBB,,35,YR,,F,Y,,,20160825,,OT,GB,GB,EFAVIRENZ,Live birth;Maternal exposure during pregnancy;Off label use;Premature delivery;Renal impairment,117628383,OT,,,117628383,1,20110102,,,,117628383,1,Antiretroviral therapy
11762840,117628402,2,F,20130411,20160825,20151120,20160901,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-18861468,BRISTOL MYERS SQUIBB,,0,DY,,M,Y,.53,KG,20160901,,OT,GB,GB,EFAVIRENZ,Foetal exposure during pregnancy;Patent ductus arteriosus;Premature baby,117628402,CA,,,117628402,1,20110102,20130411,,,117628402,1,Product used for unknown indication
11762842,117628422,2,F,20120824,20160819,20151120,20160819,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-18822858,BRISTOL MYERS SQUIBB,,0,DY,,M,Y,2.52,KG,20160819,,OT,BR,BR,EFAVIRENZ,Foetal exposure during pregnancy;Infection;Jaundice neonatal;Premature baby,117628422,HO,,,117628422,1,20080919,20090115,,,117628422,1,Product used for unknown indication
11766437,117664373,3,F,20040523,20160908,20151123,20160914,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-15152028,BRISTOL MYERS SQUIBB,,0,DY,,M,Y,2.41,KG,20160914,,CN,FR,FR,EFAVIRENZ,Congenital hydrocephalus;Foetal exposure during pregnancy;Neonatal gastrointestinal disorder;Premature baby,117664373,OT,,,117664373,1,20000401,20040102,,,117664373,1,Product used for unknown indication
11775350,117753502,2,F,20100317,20160822,20151125,20160822,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-15072168,BRISTOL MYERS SQUIBB,,36,YR,,F,Y,,,20160822,,CN,US,US,"EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",Abortion spontaneous;Maternal exposure during pregnancy,117753502,OT,,,117753502,1,20100219,20100201,,,117753502,1,Antiretroviral therapy
11809351,118093512,2,F,20060116,20160824,20151207,20160824,EXP,,BW-BRISTOL-MYERS SQUIBB COMPANY-13604434,BRISTOL MYERS SQUIBB,,33,YR,,F,Y,,,20160824,,CN,BW,BW,EFAVIRENZ,Caesarean section;Pregnancy;Stillbirth,118093512,OT,,,118093512,1,20041007,20050610,,,118093512,1,Product used for unknown indication
11809380,118093802,2,F,,20160726,20151207,20160726,EXP,,ET-BRISTOL-MYERS SQUIBB COMPANY-19912997,BRISTOL MYERS SQUIBB,,35,YR,,F,Y,,,20160726,,OT,ET,ET,EFAVIRENZ,Induced labour;Maternal exposure during pregnancy;Stillbirth,118093802,OT,,,,,,,,,118093802,1,HIV infection
11809885,118098852,2,F,20041129,20160824,20151208,20160824,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-12911863,BRISTOL MYERS SQUIBB,,36,YR,,F,Y,,,20160824,,OT,GB,GB,EFAVIRENZ,Amniotic cavity infection;Placental insufficiency;Pregnancy;Stillbirth,118098852,OT,,,,,,,,,118098852,1,HIV infection
11809892,118098922,2,F,,20160826,20151208,20160826,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2001SUS0555,BRISTOL MYERS SQUIBB,,27,YR,,F,Y,,,20160826,,OT,DE,DE,SUSTIVA,Caesarean section;Live birth;Pregnancy;Premature rupture of membranes,118098922,OT,,,118098922,2,19980501,,,,118098922,1,HIV infection
11815373,118153732,2,F,20021025,20160824,20151209,20160824,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-12155131,BRISTOL MYERS SQUIBB,,0,DY,,M,Y,1.37,KG,20160824,,OT,US,US,EFAVIRENZ,Foetal exposure during pregnancy;Patent ductus arteriosus;Premature baby,118153732,CA,,,,,,,,,118153732,1,Product used for unknown indication
11815749,118157492,2,F,20021025,20160824,20151209,20160824,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-12155560,BRISTOL MYERS SQUIBB,,27,YR,,F,Y,,,20160824,,OT,US,US,EFAVIRENZ,Live birth;Premature delivery;Twin pregnancy,118157492,OT,,,118157492,1,20020318,20020523,,,118157492,1,HIV infection
11830078,118300782,2,F,2001,20160824,20151213,20160824,EXP,,SN-BRISTOL-MYERS SQUIBB COMPANY-11885282,BRISTOL MYERS SQUIBB,,0,YR,,M,Y,2.01,KG,20160824,,OT,US,SN,EFAVIRENZ,Death;Foetal exposure during pregnancy;Foetal growth restriction;Haemorrhage;Small for dates baby,118300782,OT,,,118300782,1,20000118,20010507,,,118300782,1,Product used for unknown indication
11844732,118447322,2,F,200112,20160824,20151217,20160824,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-12160255,BRISTOL MYERS SQUIBB,,38,YR,,F,Y,,,20160824,,OT,US,US,EFAVIRENZ,Live birth;Pre-eclampsia;Pregnancy,118447322,OT,,,118447322,1,20020105,20020124,,,118447322,1,HIV infection
11848255,118482552,2,F,2000,20160824,20151217,20160824,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-12194932,BRISTOL MYERS SQUIBB,,27,YR,,F,Y,,,20160824,,OT,US,US,SUSTIVA,Abortion induced;Anaemia;Pregnancy,118482552,OT,,,118482552,1,200006,20001020,,,118482552,1,HIV infection
11853166,118531662,2,F,201107,20160825,20151218,20160826,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-16497539,BRISTOL MYERS SQUIBB,,0,YR,,M,Y,2.27,KG,20160826,,CN,US,US,EFAVIRENZ,Foetal exposure during pregnancy;Limb malformation;Premature baby,118531662,OT,,,118531662,1,20110321,20110321,,,118531662,1,Product used for unknown indication
11853192,118531922,2,F,20110728,20160825,20151218,20160825,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-16491946,BRISTOL MYERS SQUIBB,,18,YR,,F,Y,,,20160825,,CN,US,US,EFAVIRENZ,Live birth;Maternal exposure during pregnancy;Polyhydramnios;Premature delivery,118531922,OT,,,118531922,1,20081001,20110321,,,118531922,1,Antiretroviral therapy
11854637,118546372,2,F,20000101,20160826,20151221,20160826,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-2001SUS0137,BRISTOL MYERS SQUIBB,,0,YR,,M,Y,,,20160826,,MD,FR,FR,SUSTIVA,Foetal exposure during pregnancy;Pericarditis,118546372,OT,,,118546372,1,20000511,,,,118546372,1,Product used for unknown indication
11854899,118548992,2,F,20120408,20160825,20151221,20160901,EXP,,NG-BRISTOL-MYERS SQUIBB COMPANY-19223064,BRISTOL MYERS SQUIBB,,0,DY,,F,Y,1.72,KG,20160901,,CN,US,NG,EFAVIRENZ,Congenital hand malformation;Congenital hepatomegaly;Dysmorphism;Foetal exposure during pregnancy;Premature baby;Respiratory distress;Splenomegaly;Talipes;Trisomy 21,118548992,CA,,,118548992,1,20081205,20111207,,,118548992,1,Product used for unknown indication
11858629,118586292,2,F,,20160824,20151222,20160824,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2007-000002,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160824,,CN,GB,FR,SUSTIVA,Foetal exposure during pregnancy;Heart disease congenital,118586292,OT,,,118586292,1,20051201,20071211,,,118586292,1,Product used for unknown indication
11862974,118629742,2,F,20010615,20160826,20151223,20160826,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-2001SUS0779,BRISTOL MYERS SQUIBB,,0,DY,,M,Y,,,20160826,,MD,FR,FR,EFAVIRENZ,Foetal exposure during pregnancy;Foetal heart rate deceleration abnormality,118629742,OT,,,118629742,1,20001013,20001102,,,118629742,1,Product used for unknown indication
11867399,118673992,2,F,200003,20160826,20151224,20160826,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-10583250,BRISTOL MYERS SQUIBB,,4,YR,,M,Y,3.47,KG,20160826,,OT,US,FR,SUSTIVA,Abnormal behaviour;Aspartate aminotransferase increased;Blood creatine phosphokinase increased;Blood lactate dehydrogenase increased;Cardiovascular disorder;Depression;Electroencephalogram abnormal;Foetal exposure during pregnancy;Gastrointestinal disorder;Gastrointestinal haemorrhage;Haematochezia;Hepatic enzyme increased;Hypertriglyceridaemia;Lipase increased;Microcytosis;Neutropenia;Pyelonephritis;Segmented hyalinising vasculitis;Speech disorder,118673992,HO,,,118673992,5,199906,,,,118673992,1,Product used for unknown indication
11868354,118683542,2,F,20001221,20160824,20151224,20160824,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-11527520,BRISTOL MYERS SQUIBB,,37,YR,,F,Y,,,20160824,,OT,US,FR,EFAVIRENZ,Gestational diabetes;Normal newborn;Pregnancy,118683542,OT,,,118683542,1,19970902,,,,118683542,1,Antiretroviral therapy
11868474,118684742,2,F,19991110,20160824,20151225,20160824,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-10799815,BRISTOL MYERS SQUIBB,,32,YR,,F,Y,,,20160824,,OT,US,US,EFAVIRENZ,Caesarean section;Pregnancy;Premature separation of placenta,118684742,HO,,,118684742,1,19970915,19990503,,,118684742,1,HIV infection
11879892,118798922,2,F,200003,20160826,20151230,20160901,EXP,,FR-009507513-1309FRA012607,MERCK,,4,YR,,M,Y,3.47,KG,20160901,,CN,US,FR,SUSTIVA,Abnormal behaviour;Aspartate aminotransferase increased;Blood creatine phosphokinase increased;Blood lactate dehydrogenase increased;Cardiovascular disorder;Depression;Electroencephalogram abnormal;Foetal exposure during pregnancy;Gastrointestinal disorder;Gastrointestinal haemorrhage;Haematochezia;Hepatic enzyme increased;Hypertriglyceridaemia;Lipase increased;Microcytosis;Neutropenia;Pyelonephritis;Segmented hyalinising vasculitis;Speech disorder,118798922,HO,,,118798922,1,199906,2000,,,118798922,1,Product used for unknown indication
11879900,118799002,2,F,20040308,20160907,20151230,20160909,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2003-000013,BRISTOL MYERS SQUIBB,,,,N,F,Y,3.46,KG,20160909,,OT,BR,BR,EFAVIRENZ,Foetal exposure during pregnancy;Premature baby;Respiratory distress,118799002,DE,,,118799002,1,20001219,20030719,,,118799002,1,Product used for unknown indication
11881235,118812352,2,F,20140220,20160701,20151231,20160805,PER,,US-009507513-1512USA007300,MERCK,,29,YR,,F,Y,,,20160805,,CN,US,US,EFAVIRENZ,Maternal exposure during pregnancy;No adverse event;Normal newborn;Off label use,,,,,,,,,,,118812352,1,Antiretroviral therapy
11883063,118830632,2,F,,20160721,20151231,20160721,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090408,BRISTOL MYERS SQUIBB,,27,YR,,F,Y,,,20160721,,OT,PT,PT,EFAVIRENZ,Caesarean section;Drug abuse;Live birth;Maternal exposure during pregnancy,118830632,OT,,,118830632,1,2007,,,,118830632,1,HIV infection
11953570,119535702,2,F,,20160721,20160125,20160721,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-092882,BRISTOL MYERS SQUIBB,,15,MON,,M,Y,3.3,KG,20160721,,OT,PT,PT,EFAVIRENZ,Foetal exposure during pregnancy;Psychomotor skills impaired,119535702,OT,,,119535702,1,2007,,,,119535702,1,Product used for unknown indication
11969910,119699103,3,F,20151130,20160913,20160128,20160914,EXP,,UG-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-004607,BRISTOL MYERS SQUIBB,,27,YR,,F,Y,61.5,KG,20160914,,OT,UG,UG,"EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",Acute respiratory distress syndrome;Pyrexia,119699103,HO,,,119699103,1,20150408,20150501,,,119699103,1,Acquired immunodeficiency syndrome
12074101,120741012,2,F,,20160804,20160212,20160804,EXP,,AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-009817,BRISTOL MYERS SQUIBB,MYCOBACTERIUM HAEMNOPHILUM BONE AND JOINT INFECTION IN HIV/AIDS: CASE REPORT AND LITERATURE REVIEW,60,YR,,M,Y,,,20160804,,MD,AU,AU,EFAVIRENZ,Debridement;Haemophilus infection;Immune reconstitution inflammatory syndrome,120741012,OT,,,,,,,,,120741012,1,Antiretroviral therapy
12117440,121174404,4,F,20160125,20160719,20160225,20160728,EXP,,ZA-GILEAD-2016-0199511,GILEAD,,49,YR,A,M,Y,81.8,KG,20160728,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Cognitive disorder,121174404,HO,,,121174404,1,20130425,20160118,,,121174404,1,HIV infection
12122454,121224543,3,F,20151015,20160803,20160226,20160812,EXP,,PT-GILEAD-2016-0195982,GILEAD,,54,YR,A,M,Y,53,KG,20160812,,MD,PT,PT,EFAVIRENZ,Renal impairment;Renal tubular dysfunction,121224543,OT,,,121224543,1,20151001,20151224,,,121224543,1,Hepatitis C
12171229,121712292,2,F,,20160715,20160311,20160715,EXP,,TH-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-016765,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160715,,OT,COUNTRY NOT SPECIFIED,TH,EFAVIRENZ,Hypotension;Labelled drug-drug interaction medication error;Peripheral ischaemia,121712292,OT,,,,,,,,,121712292,1,HIV infection
12177888,121778883,3,F,,20160722,20160314,20160722,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-018229,BRISTOL MYERS SQUIBB,,42,YR,,M,Y,,,20160722,,OT,JP,JP,EFAVIRENZ,Lactic acidosis,121778883,OT,,,,,,,,,121778883,1,HIV infection
12203023,122030233,3,F,,20160715,20160323,20160725,EXP,,US-009507513-1603USA008975,MERCK,,58,YR,,F,Y,,,20160725,,CN,US,US,EFAVIRENZ,Drug ineffective,122030233,OT,,,,,,,,,122030233,1,HIV infection
12211624,122116242,2,F,,20160715,20160325,20160715,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-022907,BRISTOL MYERS SQUIBB,,58,YR,,F,Y,,,20160715,,OT,US,US,EFAVIRENZ,Drug ineffective,122116242,OT,,,,,,,,,122116242,1,HIV infection
12235868,122358685,5,F,20160117,20160713,20160404,20160720,EXP,,GB-BMSGILMSD-2016-0199508,GILEAD,,44,YR,A,M,Y,60,KG,20160720,,OT,GB,GB,BLINDED EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Fall;Traumatic intracranial haemorrhage,122358685,OT,,,122358685,1,20151223,,,,122358685,1,HIV infection
12315941,123159412,2,F,20150701,20160626,20160428,20160701,EXP,,VN-BMSGILMSD-2016-0210281,GILEAD,,45,YR,A,M,Y,,,20160701,,OT,VN,VN,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Diabetes mellitus,123159412,OT,,,123159412,1,20140329,20150701,,,123159412,1,HIV infection
12343974,123439743,3,F,201404,20160721,20160507,20160912,PER,,US-JNJFOC-20160409322,JANSSEN,,81,YR,E,F,Y,,,20160912,,CN,US,US,SUSTIVA,Gastrointestinal haemorrhage;Peptic ulcer haemorrhage,123439743,HO,,,123439743,1,20140405,20140410,,,123439743,1,Atrial fibrillation
12346285,123462852,2,F,200701,20160719,20160509,20160727,PER,,US-PFIZER INC-2016245583,PFIZER,,51,YR,,M,Y,,,20160727,,LW,US,US,SUSTIVA,Deep vein thrombosis;Mental disorder;Pulmonary embolism,123462852,OT,,,123462852,1,200010,201504,,,123462852,1,Hormone replacement therapy
12376226,123762264,4,F,20150814,20160624,20160517,20160701,EXP,,US-009507513-1605USA007674,MERCK,,54,YR,,M,Y,65.76,KG,20160701,,CN,US,US,SUSTIVA,Arthralgia;Arthritis;Depression;Drug abuse;Drug dependence;Drug withdrawal syndrome;Intentional self-injury;Joint stiffness;Ligament disorder;Suicide attempt;Tendon disorder,123762264,OT,,,123762264,1,2010,,,,123762264,1,Type 2 diabetes mellitus
12391320,123913203,3,F,20160505,20160811,20160520,20160816,EXP,,MZ-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-039437,BRISTOL MYERS SQUIBB,,41,YR,,M,Y,54,KG,20160816,,OT,MZ,MZ,EFAVIRENZ,Acute kidney injury;Neuropathy peripheral;Transaminases increased;Urinary tract infection,123913203,HO,,,123913203,1,20160330,20160513,,,123913203,1,HIV infection
12394873,123948732,2,F,2015,20160708,20160523,20160713,EXP,,GB-JNJFOC-20160516218,JANSSEN,,37,YR,A,M,Y,,,20160713,,MD,GB,GB,EFAVIRENZ W/EMTRICITABINE/TENOFOVIR DISOPROXI,Drug ineffective;Seizure;Somnolence;Unresponsive to stimuli,123948732,HO,,,123948732,2,2008,,,,123948732,1,Seizure
12404262,124042623,3,F,20130320,20160803,20160525,20160810,EXP,,IT-BMSGILMSD-2016-0215006,GILEAD,,55,YR,A,M,Y,112,KG,20160810,,MD,IT,IT,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Osteopenia;Osteoporosis,124042623,OT,,,124042623,1,20100524,,,,124042623,1,HIV infection
12433610,124336103,3,F,20160525,20160811,20160603,20160815,EXP,,DE-GILEAD-2016-0215798,GILEAD,,49,YR,A,M,Y,84.2,KG,20160815,,OT,DE,DE,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Atrial fibrillation,124336103,OT,,,124336103,1,20150622,20160525,,,124336103,1,HIV infection
12455220,124552202,2,F,20160314,20160728,20160610,20160805,EXP,,ZA-JNJFOC-20160601626,JANSSEN,,55,YR,A,M,Y,56.2,KG,20160805,,MD,ZA,ZA,EFAVIRENZ W/EMTRICITABINE/TENOFOVIR DISOPROXI,Diarrhoea;Electrocardiogram QT prolonged;Tinnitus;Vomiting,124552202,OT,,,124552202,1,20160310,20160316,,,124552202,1,Tuberculosis
12459270,124592704,4,F,,20160819,20160613,20160825,EXP,GB-MHRA-ADR 23523460,GB-VIIV HEALTHCARE LIMITED-GB2016GSK083624,VIIV,,,,,M,Y,,,20160825,,CN,GB,GB,SUSTIVA,Cerebral haemorrhage;Rib fracture;Road traffic accident,124592704,HO,,,,,,,,,124592704,1,Product used for unknown indication
12474952,124749524,4,F,,20160819,20160617,20160829,EXP,GB-MHRA-ADR 23523460,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-046986,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20160829,,CN,GB,GB,SUSTIVA,Cerebral haemorrhage;Rib fracture;Road traffic accident,124749524,OT,,,,,,,,,124749524,1,Short-bowel syndrome
12485003,124850033,3,F,,20160819,20160621,20160825,EXP,GB-MHRA-ADR 23523460,GB-GLAXOSMITHKLINE-GB2016GSK083624,GLAXOSMITHKLINE,,,,,M,Y,,,20160825,,CN,GB,GB,SUSTIVA,Cerebral haemorrhage;Rib fracture;Road traffic accident,124850033,OT,,,,,,,,,124850033,1,Product used for unknown indication
12490356,124903563,3,F,20160613,20160708,20160622,20160714,EXP,,MW-GILEAD-2016-0219942,GILEAD,,38,YR,A,M,Y,,,20160714,,MD,MW,MW,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Anaemia;Bacterial sepsis;Disseminated tuberculosis,124903563,HO,,,124903563,1,20150717,20160612,,,124903563,1,Acquired immunodeficiency syndrome
12505909,125059092,2,F,,20160712,20160628,20160713,EXP,,GB-BMSGILMSD-2016-0220050,GILEAD,,,,,M,Y,,,20160713,,CN,GB,GB,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Death,125059092,OT,,,,,,,,,125059092,1,HIV infection
12519404,125194041,1,I,,20160620,20160701,20160701,EXP,,GB-HETERO LABS LTD-1054500,HETERO,,38,YR,,M,Y,,,20160701,,CN,GB,GB,Efavirenz,Cerebral haemorrhage;Rib fracture,125194041,HO,,,,,,,,,125194041,1,Product used for unknown indication
12522806,125228061,1,I,,20160623,20160701,20160701,EXP,,AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-052722,BRISTOL MYERS SQUIBB,,50,YR,,M,Y,,,20160701,,CN,AU,AU,EFAVIRENZ,Depression;Lipodystrophy acquired;Myalgia;Neuropathy peripheral,125228061,OT,,,,,,,,,125228061,1,Product used for unknown indication
12527264,125272642,2,F,,20160721,20160705,20160726,EXP,,AU-VIIV HEALTHCARE LIMITED-AU2016GSK095408,VIIV,,,,,M,Y,60,KG,20160726,,MD,AU,AU,Efavirenz,Atrial fibrillation,125272642,OT,,,125272642,1,201603,201603,,,125272642,1,Product used for unknown indication
12528907,125289072,2,F,20160421,20160623,20160705,20160705,EXP,,UG-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-034189,BRISTOL MYERS SQUIBB,,36,YR,,M,Y,60,KG,20160705,,CN,US,UG,"EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",Encephalitis;Neutropenia,125289072,OT,,,125289072,1,20151021,,,,125289072,1,Acquired immunodeficiency syndrome
12529856,125298561,1,I,,20160629,20160706,20160706,EXP,,PHHY2016CO091302,NOVARTIS,,,,,M,Y,52,KG,20160706,,CN,COUNTRY NOT SPECIFIED,CO,EFAVIRENZ,Abdominal discomfort;Asthenia;Muscle spasms,,,,,,,,,,,125298561,1,Chronic myeloid leukaemia
12530506,125305061,1,I,,20160628,20160706,20160706,EXP,,ZA-GLAXOSMITHKLINE-ZA2016GSK095757,GLAXOSMITHKLINE,,61,YR,,F,Y,,,20160706,,OT,ZA,ZA,EFAVIRENZ,Drug resistance;Hepatitis B;Treatment failure;Virologic failure,125305061,OT,,,,,,,,,125305061,1,HIV infection
12531024,125310241,1,I,,20160628,20160706,20160706,EXP,,ZA-VIIV HEALTHCARE LIMITED-ZA2016GSK095757,VIIV,,61,YR,,F,Y,,,20160706,,OT,ZA,ZA,EFAVIRENZ,Drug resistance;Hepatitis B;Treatment failure;Virologic failure,125310241,OT,,,,,,,,,125310241,1,HIV infection
12537541,125375411,1,I,,20160628,20160707,20160707,EXP,,US-BMSGILMSD-2016-0221435,GILEAD,,66,YR,E,M,Y,,,20160707,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Diabetes mellitus;Hypertension,125375411,OT,,,,,,,,,125375411,1,HIV infection
12538327,125383271,1,I,,20160628,20160707,20160707,EXP,,US-BMSGILMSD-2016-0221256,GILEAD,,56,YR,A,M,Y,,,20160707,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Blood glucose increased;Cardiac arrest;Myocardial infarction;Stent placement,125383271,OT,,,,,,,,,125383271,1,HIV infection
12542248,125422481,1,I,20000405,20160628,20160708,20160708,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055352,BRISTOL MYERS SQUIBB,,48,YR,,M,Y,,,20160708,,MD,JP,JP,EFAVIRENZ,Hyperlipidaemia;Lipodystrophy acquired;Liver disorder,125422481,OT,,,125422481,1,20000613,20010814,,,125422481,1,HIV infection
12544841,125448411,1,I,,20160628,20160711,20160711,EXP,,ZA-VIIV HEALTHCARE LIMITED-ZA2016GSK095831,VIIV,,44,YR,,M,Y,,,20160711,,OT,ZA,ZA,EFAVIRENZ,Drug resistance;Hepatitis B;Treatment failure;Virologic failure,125448411,OT,,,,,,,,,125448411,1,HIV infection
12544842,125448421,1,I,,20160628,20160711,20160711,EXP,,ZA-VIIV HEALTHCARE LIMITED-ZA2016GSK095830,VIIV,,23,YR,,F,Y,,,20160711,,OT,ZA,ZA,EFAVIRENZ,Drug resistance;Hepatitis B;Treatment failure;Virologic failure,125448421,OT,,,,,,,,,125448421,1,HIV infection
12544843,125448431,1,I,,20160628,20160711,20160711,EXP,,ZA-VIIV HEALTHCARE LIMITED-ZA2016GSK095832,VIIV,,23,YR,,M,Y,,,20160711,,OT,ZA,ZA,EFAVIRENZ,Drug resistance;Hepatitis B;Treatment failure;Virologic failure,125448431,OT,,,,,,,,,125448431,1,HIV infection
12546454,125464542,2,F,20160628,20160701,20160711,20160901,EXP,,US-RELYPSA-RLY2016001276,RELYPSA,,66,YR,,M,Y,,,20160901,,CN,US,US,SUSTIVA,Thrombosis,125464542,HO,,,125464542,1,20160606,20160628,,,125464542,1,Hyperkalaemia
12546700,125467001,1,I,,20160628,20160711,20160711,EXP,,ZA-GLAXOSMITHKLINE-ZA2016GSK095832,GLAXOSMITHKLINE,,23,YR,,M,Y,,,20160711,,OT,ZA,ZA,EFAVIRENZ,Drug resistance;Hepatitis B;Treatment failure;Virologic failure,125467001,OT,,,,,,,,,125467001,1,HIV infection
12546701,125467011,1,I,,20160628,20160711,20160711,EXP,,ZA-GLAXOSMITHKLINE-ZA2016GSK095830,GLAXOSMITHKLINE,,23,YR,,F,Y,,,20160711,,OT,ZA,ZA,EFAVIRENZ,Drug resistance;Hepatitis B;Treatment failure;Virologic failure,125467011,OT,,,,,,,,,125467011,1,HIV infection
12546702,125467021,1,I,,20160628,20160711,20160711,EXP,,ZA-GLAXOSMITHKLINE-ZA2016GSK095831,GLAXOSMITHKLINE,,44,YR,,M,Y,,,20160711,,OT,ZA,ZA,EFAVIRENZ,Drug resistance;Hepatitis B;Treatment failure;Virologic failure,125467021,OT,,,,,,,,,125467021,1,HIV infection
12550531,125505311,1,I,,20160706,20160712,20160712,EXP,,CA-ABBVIE-16P-028-1672373-00,ABBVIE,,,,,M,Y,,,20160712,,OT,CA,CA,SUSTIVA,Depression;Drug interaction,125505311,OT,,,,,,,,,125505311,1,Product used for unknown indication
12553154,125531541,1,I,20160415,20160705,20160713,20160713,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055802,BRISTOL MYERS SQUIBB,,21,YR,,M,Y,50,KG,20160713,,CN,FR,FR,SUSTIVA,Hypoglycaemia;Hypothermia,125531541,HO,,,,,,,,,125531541,1,HIV infection
12553310,125533101,1,I,20160415,20160705,20160713,20160713,EXP,,FR-JNJFOC-20160703774,JANSSEN,,21,YR,A,M,Y,50,KG,20160713,,OT,FR,FR,SUSTIVA,Hypoglycaemia;Hypothermia,125533101,HO,,,,,,,,,125533101,1,HIV infection
12558255,125582551,1,I,20160415,20160707,20160714,20160714,EXP,,FR-ABBVIE-16P-056-1674189-00,ABBVIE,,21,YR,,M,Y,50,KG,20160714,,MD,FR,FR,SUSTIVA,Hypoglycaemia;Hypothermia,125582551,HO,,,,,,,,,125582551,1,Product used for unknown indication
12563120,125631202,2,F,20000322,20160715,20160715,20160726,EXP,,JP-009507513-01062443,MERCK,,42,YR,,M,Y,,,20160726,,CN,US,JP,EFAVIRENZ,Hepatic cirrhosis;Hypertriglyceridaemia;Pancytopenia,125631202,OT,,,125631202,1,19990819,20040331,,,125631202,1,HIV infection
12563472,125634723,3,F,20000322,20160720,20160715,20160727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2001SUS0617,BRISTOL MYERS SQUIBB,,42,YR,,M,Y,,,20160727,,MD,JP,JP,EFAVIRENZ,Hepatic cirrhosis;Hypertriglyceridaemia;Pancytopenia,125634723,OT,,,125634723,1,19990819,20040331,,,125634723,1,HIV infection
12564709,125647092,2,F,,20160704,20160718,20160718,EXP,,UG-CIPLA LTD.-2016UG09322,CIPLA,"RHEIN J, MORAWSKI BM, HULLSIEK KH, NABETA HW, KIGGUNDU R, TUGUME L ET AL.,. EFFICACY OF ADJUNCTIVE SERTRALINE FOR THE TREATMENT OF HIV-ASSOCIATED CRYPTOCOCCAL MENINGITIS: AN OPEN-LABEL DOSE-RANGING STUDY. LANCET INFECT DIS. 2016;16:809 TO 818",,,,,Y,,,20160718,,OT,UG,UG,Efavirenz,Immune reconstitution inflammatory syndrome,125647092,OT,,,,,,,,,125647092,1,Antiretroviral therapy
12564898,125648982,2,F,,20160704,20160718,20160718,EXP,,UG-CIPLA LTD.-2016UG09323,CIPLA,"RHEIN J, MORAWSKI BM, HULLSIEK KH, NABETA HW, KIGGUNDU R, TUGUME L ET AL.,. EFFICACY OF ADJUNCTIVE SERTRALINE FOR THE TREATMENT OF HIV-ASSOCIATED CRYPTOCOCCAL MENINGITIS: AN OPEN-LABEL DOSE-RANGING STUDY. LANCET INFECT DIS. 2016;16:809 TO18",,,,,Y,,,20160718,,OT,UG,UG,Efavirenz,Medication error;Serotonin syndrome,125648982,OT,,,,,,,,,125648982,1,Antiretroviral therapy
12564934,125649342,2,F,,20160704,20160718,20160718,EXP,,UG-CIPLA LTD.-2016UG09324,CIPLA,"RHEIN J, MORAWSKI BM, HULLSIEK KH, NABETA HW, KIGGUNDU R, TUGUME L ET AL.,. EFFICACY OF ADJUNCTIVE SERTRALINE FOR THE TREATMENT OF HIV-ASSOCIATED CRYPTOCOCCAL MENINGITIS: AN OPEN-LABEL DOSE-RANGING STUDY. LANCET INFECT DIS. 2016;16:809 TO 818",,,,,Y,,,20160718,,OT,UG,UG,Efavirenz,Adverse event,125649342,DE,,,,,,,,,125649342,1,Antiretroviral therapy
12564941,125649412,2,F,,20160704,20160718,20160718,EXP,,UG-CIPLA LTD.-2016UG09326,CIPLA,"RHEIN J, MORAWSKI BM, HULLSIEK KH, NABETA HW, KIGGUNDU R, TUGUME L ET AL.,. EFFICACY OF ADJUNCTIVE SERTRALINE FOR THE TREATMENT OF HIV-ASSOCIATED CRYPTOCOCCAL MENINGITIS: AN OPEN-LABEL DOSE-RANGING STUDY. LANCET INFECT DIS. 2016;16:809 TO 818",,,,,Y,,,20160718,,OT,UG,UG,Efavirenz,Adverse event,125649412,OT,,,,,,,,,125649412,1,Antiretroviral therapy
12564968,125649682,2,F,,20160704,20160718,20160718,EXP,,UG-CIPLA LTD.-2016UG09367,CIPLA,"RHEIN J, MORAWSKI BM, HULLSIEK KH, NABETA HW, KIGGUNDU R, TUGUME L ET.AL. EFFICACY OF ADJUNCTIVE SERTRALINE FOR THE TREATMENT OF HIV-ASSOCIATED CRYPTOCOCCAL MENINGITIS: AN OPEN-LABEL DOSE-RANGING STUDY. LANCET INFECT DIS. 2016;16:809 TO 818",,,,,Y,,,20160718,,OT,UG,UG,Efavirenz,Meningitis cryptococcal,125649682,OT,,,,,,,,,125649682,1,Meningitis cryptococcal
12564969,125649692,2,F,,20160704,20160718,20160718,EXP,,UG-CIPLA LTD.-2016UG09366,CIPLA,"RHEIN J, MORAWSKI BM, HULLSIEK KH, NABETA HW, KIGGUNDU R, TUGUME L ET AL.,. EFFICACY OF ADJUNCTIVE SERTRALINE FOR THE TREATMENT OF HIV-ASSOCIATED CRYPTOCOCCAL MENINGITIS: AN OPEN-LABEL DOSE-RANGING STUDY. LANCET INFECT DIS. 2016;16:809 TO 818",,,,,Y,,,20160718,,OT,UG,UG,Efavirenz,Immune reconstitution inflammatory syndrome,125649692,OT,,,,,,,,,125649692,1,Antiretroviral therapy
12564980,125649802,2,F,,20160704,20160718,20160718,EXP,,UG-CIPLA LTD.-2016UG09368,CIPLA,"RHEIN J, MORAWSKI BM, HULLSIEK KH, NABETA HW, KIGGUNDU R, TUGUME L ET AL.,. EFFICACY OF ADJUNCTIVE SERTRALINE FOR THE TREATMENT OF HIV ASSOCIATED CRYPTOCOCCAL MENINGITIS: AN OPEN LABEL DOSE RANGING STUDY. LANCET INFECT DIS. 2016;16:809 TO 818",,,,,Y,,,20160718,,OT,UG,UG,Efavirenz,Meningitis cryptococcal;Treatment noncompliance,125649802,OT,,,,,,,,,125649802,1,Meningitis cryptococcal
12566773,125667732,2,F,20160707,20160722,20160718,20160729,EXP,,ZW-GILEAD-2016-0223808,GILEAD,,52,YR,A,M,Y,,,20160729,,MD,ZW,ZW,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Kaposi's sarcoma;Sepsis,125667732,HO,,,125667732,1,20150305,20150916,,,125667732,1,Kaposi's sarcoma AIDS related
12566853,125668531,1,I,,20160711,20160718,20160718,EXP,,ZA-BMSGILMSD-2016-0223383,GILEAD,,27,YR,A,F,Y,,,20160718,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abortion spontaneous;Maternal exposure during pregnancy,125668531,OT,,,125668531,1,20150302,,,,125668531,1,HIV infection
12567139,125671391,1,I,20050627,20050919,20160718,20160718,EXP,,LS-BRISTOL-MYERS SQUIBB COMPANY-13114491,BRISTOL MYERS SQUIBB,,26,YR,,M,Y,,,20160718,,CN,ZA,LS,EFAVIRENZ,Liver function test increased;Meningitis tuberculous;Tuberculoma of central nervous system,125671391,HO,,,125671391,1,20040826,20050908,,,125671391,1,HIV infection
12567182,125671823,3,F,20160603,20160829,20160718,20160908,EXP,,FR-GILEAD-2016-0223323,GILEAD,,33,YR,A,M,Y,68,KG,20160908,,MD,FR,FR,EFAVIRENZ;SUSTIVA,Atrial flutter;Cardiac failure;Myocarditis,125671823,OT,,,125671823,1,20160405,20160628,,,125671823,1,Chronic hepatitis C
12571446,125714461,1,I,,20160713,20160719,20160719,EXP,,US-GILEAD-2016-0223728,GILEAD,,56,YR,A,F,Y,,,20160719,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Hypersensitivity;Osteoporosis,125714461,OT,,,,,,,,,125714461,1,HIV infection
12573141,125731412,2,F,20160115,20160722,20160720,20160729,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-058241,BRISTOL MYERS SQUIBB,,25,YR,,M,Y,67,KG,20160729,,CN,CN,CN,EFAVIRENZ,Liver injury,125731412,HO,,,125731412,1,20140603,20160115,,,125731412,1,HIV infection
12573161,125731611,1,I,20160227,20160711,20160720,20160720,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-058279,BRISTOL MYERS SQUIBB,,28,YR,,M,Y,60,KG,20160720,,CN,CN,CN,EFAVIRENZ,Dermatitis exfoliative,125731611,OT,,,125731611,1,20160202,20160227,,,125731611,1,Viral infection
12573363,125733632,2,F,,20160722,20160720,20160722,EXP,,CI-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059004,BRISTOL MYERS SQUIBB,,38,YR,,F,Y,63,KG,20160722,,OT,CI,CI,EFAVIRENZ,Cholestasis;Coagulopathy,125733632,OT,,,,,,,,,125733632,1,HIV infection
12575241,125752411,1,I,20160707,20160714,20160720,20160720,EXP,,IT-BMSGILMSD-2016-0223757,GILEAD,,59,YR,A,M,Y,79,KG,20160720,,MD,IT,IT,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DF,Osteoporosis,125752411,OT,,,125752411,1,20081010,,,,125752411,1,HIV infection
12575801,125758011,1,I,,20160708,20160720,20160720,EXP,,"DE-IMPAX LABORATORIES, INC-2016-IPXL-00759",IMPAX,,43,YR,,M,Y,80,KG,20160720,,MD,DE,DE,EFAVIRENZ,Acute prerenal failure;Coma scale abnormal;Intervertebral discitis;Overdose;Poisoning,125758011,HO,,,,,,,,,125758011,1,Drug dependence
12576304,125763041,1,I,,20160708,20160720,20160720,EXP,,US-ACTAVIS-2016-15466,WATSON,"KHALIL C, MOHANTY MJ, KAATZ G, ABU-HAMDAN D. EFAVIRENZ-ASSOCIATED URINARY MATRIX STONE - A RARE PRESENTATION. AM J MED SCI. 2016;351(2):213-4",65,YR,,M,Y,,,20160720,,MD,US,US,Efavirenz (Unknown),Drug resistance;Nephrolithiasis,125763041,OT,,,,,,,,,125763041,1,HIV infection
12581733,125817331,1,I,20160129,20160711,20160722,20160722,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-058289,BRISTOL MYERS SQUIBB,,34,YR,,M,Y,50,KG,20160722,,CN,CN,CN,EFAVIRENZ,Drug eruption,125817331,OT,,,125817331,1,20160125,20160129,,,125817331,1,HIV infection
12584418,125844182,2,F,20160421,20160804,20160722,20160811,EXP,,US-GILEAD-2016-0224201,GILEAD,,62,YR,A,M,Y,58.5,KG,20160811,,MD,US,US,EFAVIRENZ,Blood creatinine increased;Glomerular filtration rate decreased,125844182,OT,,,125844182,1,20160314,20160502,,,125844182,1,HIV infection
12586101,125861011,1,I,,20160203,20160725,20160725,PER,,US-JAZZ-2016-US-002065,JAZZ,,,,,M,Y,,,20160725,,,US,US,Efavirenz,Gastroenteritis viral;Gastrooesophageal reflux disease,,,,,125861011,1,201507,201507,,,125861011,1,Narcolepsy
12591485,125914851,1,I,,20160615,20160726,20160726,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-051257,BRISTOL MYERS SQUIBB,,,,I,M,Y,,,20160726,,OT,GB,GB,EFAVIRENZ,Cryptorchism;Foetal exposure during pregnancy,125914851,CA,,,,,,,,,125914851,1,Product used for unknown indication
12591611,125916111,1,I,,20160623,20160726,20160726,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-056735,BRISTOL MYERS SQUIBB,,,,I,,Y,,,20160726,,OT,GB,GB,EFAVIRENZ,Developmental hip dysplasia;Foetal exposure during pregnancy,125916111,CA,,,,,,,,,125916111,1,Product used for unknown indication
12591612,125916121,1,I,,20160623,20160726,20160726,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-056733,BRISTOL MYERS SQUIBB,,,,I,M,Y,,,20160726,,OT,GB,GB,EFAVIRENZ,Cryptorchism;Foetal exposure during pregnancy,125916121,CA,,,,,,,,,125916121,1,Product used for unknown indication
12591617,125916171,1,I,,20160623,20160726,20160726,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-056734,BRISTOL MYERS SQUIBB,,,,I,,Y,,,20160726,,OT,GB,GB,EFAVIRENZ,Developmental hip dysplasia;Foetal exposure during pregnancy,125916171,OT,,,,,,,,,125916171,1,Product used for unknown indication
12592191,125921911,1,I,,20160623,20160726,20160726,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-056736,BRISTOL MYERS SQUIBB,,,,I,,Y,,,20160726,,OT,GB,GB,EFAVIRENZ,Foetal exposure during pregnancy;Pyloric stenosis,125921911,OT,,,,,,,,,125921911,1,Product used for unknown indication
12592628,125926281,1,I,,20160630,20160726,20160726,EXP,,AU-GLAXOSMITHKLINE-AU2016GSK095408,GLAXOSMITHKLINE,,,,,M,Y,60,KG,20160726,,MD,AU,AU,Efavirenz,Atrial fibrillation,125926281,OT,,,125926281,1,201603,201603,,,125926281,1,Product used for unknown indication
12595732,125957321,1,I,,20160719,20160727,20160727,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-061114,BRISTOL MYERS SQUIBB,,23,YR,,F,Y,,,20160727,,OT,ZA,ZA,EFAVIRENZ,Autoimmune hepatitis;Overlap syndrome,125957321,OT,,,,,,,,,125957321,1,HIV infection
12596861,125968611,1,I,,20160719,20160727,20160727,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-061581,BRISTOL MYERS SQUIBB,,36,YR,,F,Y,,,20160727,,OT,ZA,ZA,EFAVIRENZ,Autoimmune hepatitis,125968611,OT,,,,,,,,,125968611,1,HIV infection
12596864,125968641,1,I,,20160719,20160727,20160727,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-061578,BRISTOL MYERS SQUIBB,,39,YR,,M,Y,,,20160727,,OT,ZA,ZA,EFAVIRENZ,Autoimmune hepatitis,125968641,OT,,,,,,,,,125968641,1,HIV infection
12596882,125968821,1,I,,20160719,20160727,20160727,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-061579,BRISTOL MYERS SQUIBB,,39,YR,,F,Y,,,20160727,,OT,ZA,ZA,EFAVIRENZ,Autoimmune hepatitis,125968821,OT,,,,,,,,,125968821,1,HIV infection
12596893,125968931,1,I,,20160719,20160727,20160727,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-061580,BRISTOL MYERS SQUIBB,,43,YR,,F,Y,,,20160727,,OT,ZA,ZA,EFAVIRENZ,Autoimmune hepatitis,125968931,OT,,,,,,,,,125968931,1,HIV infection
12596900,125969001,1,I,,20160719,20160727,20160727,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-061577,BRISTOL MYERS SQUIBB,,45,YR,,F,Y,,,20160727,,OT,ZA,ZA,EFAVIRENZ,Autoimmune hepatitis,125969001,OT,,,,,,,,,125969001,1,HIV infection
12596901,125969011,1,I,,20160719,20160727,20160727,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-061576,BRISTOL MYERS SQUIBB,,42,YR,,F,Y,,,20160727,,OT,ZA,ZA,EFAVIRENZ,Autoimmune hepatitis;Overlap syndrome,125969011,OT,,,,,,,,,125969011,1,HIV infection
12597577,125975771,1,I,,20160719,20160726,20160726,EXP,,ZA-MYLANLABS-2016M1030402,MYLAN,"MURUNGA E, ANDERSSON M, RENSBURG CV. AUTOIMMUNE HEPATITIS: A MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN HIV INFECTED PATIENTS?. SCAND-J-GASTROENTEROL 2016;51(7):814-818.",,,,,Y,,,20160726,,MD,ZA,ZA,EFAVIRENZ,Autoimmune hepatitis;Immune reconstitution inflammatory syndrome,125975771,OT,,,,,,,,,125975771,1,HIV infection
12597608,125976081,1,I,,20160719,20160726,20160726,EXP,,ZA-MYLANLABS-2016M1030423,MYLAN,"MURUNGA E, ANDERSSON M, RENSBURG CV. AUTOIMMUNE HEPATITIS: A MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN HIV INFECTED PATIENTS?. SCAND-J-GASTROENTEROL 2016;51(7):814-818.",,,,,Y,,,20160726,,MD,ZA,ZA,EFAVIRENZ,Autoimmune hepatitis;Immune reconstitution inflammatory syndrome,125976081,OT,,,,,,,,,125976081,1,HIV infection
12597611,125976111,1,I,,20160719,20160726,20160726,EXP,,ZA-MYLANLABS-2016M1030419,MYLAN,"MURUNGA E, ANDERSSON M, RENSBURG CV. AUTOIMMUNE HEPATITIS: A MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN HIV INFECTED PATIENTS?. SCAND-J-GASTROENTEROL 2016;51(7):814-818.",,,,,Y,,,20160726,,MD,ZA,ZA,EFAVIRENZ,Autoimmune hepatitis;Immune reconstitution inflammatory syndrome;Overlap syndrome,125976111,OT,,,,,,,,,125976111,1,HIV infection
12597622,125976221,1,I,,20160719,20160726,20160726,EXP,,ZA-MYLANLABS-2016M1030427,MYLAN,"MURUNGA E, ANDERSSON M, RENSBURG CV. AUTOIMMUNE HEPATITIS: A MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN HIV INFECTED PATIENTS?. SCAND-J-GASTROENTEROL 2016;51(7):814-818.",,,,,Y,,,20160726,,MD,ZA,ZA,EFAVIRENZ,Autoimmune hepatitis;Immune reconstitution inflammatory syndrome,125976221,OT,,,,,,,,,125976221,1,HIV infection
12597632,125976321,1,I,,20160719,20160726,20160726,EXP,,ZA-MYLANLABS-2016M1030429,MYLAN,"MURUNGA E, ANDERSSON M, RENSBURG CV. AUTOIMMUNE HEPATITIS: A MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN HIV INFECTED PATIENTS?. SCAND-J-GASTROENTEROL 2016;51(7):814-818.",,,,,Y,,,20160726,,MD,ZA,ZA,EFAVIRENZ,Autoimmune hepatitis;Immune reconstitution inflammatory syndrome,125976321,OT,,,,,,,,,125976321,1,HIV infection
12597659,125976591,1,I,,20160719,20160726,20160726,EXP,,ZA-MYLANLABS-2016M1030432,MYLAN,"MURUNGA E, ANDERSSON M, RENSBURG CV. AUTOIMMUNE HEPATITIS: A MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN HIV INFECTED PATIENTS?. SCAND-J-GASTROENTEROL 2016;51(7):814-818.",,,,,Y,,,20160726,,MD,ZA,ZA,EFAVIRENZ,Autoimmune hepatitis;Immune reconstitution inflammatory syndrome,125976591,OT,,,,,,,,,125976591,1,HIV infection
12597712,125977121,1,I,,20160719,20160726,20160726,EXP,,ZA-MYLANLABS-2016M1030440,MYLAN,"MURUNGA E, ANDERSSON M, RENSBURG CV. AUTOIMMUNE HEPATITIS: A MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN HIV INFECTED PATIENTS?. SCAND-J-GASTROENTEROL 2016;51(7):814-818.",,,,,Y,,,20160726,,MD,ZA,ZA,EFAVIRENZ,Autoimmune hepatitis;Immune reconstitution inflammatory syndrome;Overlap syndrome,125977121,OT,,,,,,,,,125977121,1,HIV infection
12597963,125979631,1,I,,20151203,20160727,20160727,EXP,,PT-MYLANLABS-2015M1044124,MYLAN,"CRISTINA VAZ PEREIRA, MONICA FRANCO, RITA PINTO WAR ET,AL.. BULL?S EYE MACULOPATHY IN A BULL?S EYE MACULOPATHY IN A PATIENT TREATED WITH EFAVIRENZ. OFTALMOLOGIA. 2015;38:69-72",37,YR,,F,Y,,,20160727,,OT,PT,PT,EFAVIRENZ,Blindness;Dizziness;Fatigue;Insomnia,125979631,OT,,,,,,,,,125979631,1,Product used for unknown indication
12598438,125984383,3,F,20140227,20160822,20160726,20160830,EXP,,CH-BMSGILMSD-2016-0225011,GILEAD,,57,YR,A,M,Y,49.4,KG,20160830,,MD,CH,CH,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Osteoporosis,125984383,OT,,,125984383,1,20111111,20150115,,,125984383,1,HIV infection
12598946,125989461,1,I,20160128,20160711,20160726,20160726,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-058297,BRISTOL MYERS SQUIBB,,51,YR,,M,Y,65,KG,20160726,,CN,CN,CN,EFAVIRENZ,Drug eruption,125989461,HO,,,125989461,1,20160125,20160201,,,125989461,1,HIV infection
12599069,125990691,1,I,,20160718,20160727,20160727,EXP,,IN-STRIDES ARCOLAB LIMITED-2016SP010190,STRIDES,"BUDAMAKUNTLA L, LOGANATHAN E, SURYANARAYAN S, ABHISHEK K, SARVAJNAMURTHY S. NEVIRAPINE INDUCED TOXIC EPIDERMAL NECROLYSIS AND NON-HODGKIN LYMPHOMA IN A HUMAN IMMUNODEFICIENCY VIRUS POSITIVE PATIENT. INDIAN DERMATOL ONLINE J. 2014;5(2):179-181",,,,,Y,,,20160727,,MD,IN,IN,EFAVIRENZ,Dermatitis bullous;Drug-induced liver injury;Genital erosion;Leukopenia;Lower respiratory tract infection;Nikolsky's sign;Oral mucosa erosion;Pruritus;Rash maculo-papular;Skin exfoliation;Toxic epidermal necrolysis,125990691,HO,,,,,,,,,125990691,1,HIV infection
12601807,126018071,1,I,20160104,20160711,20160728,20160728,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-058254,BRISTOL MYERS SQUIBB,,46,YR,,M,Y,54,KG,20160728,,CN,CN,CN,EFAVIRENZ,Mouth haemorrhage;Mouth ulceration;Rash,126018071,OT,,,126018071,1,20151224,20160104,,,126018071,1,Acquired immunodeficiency syndrome
12604563,126045634,4,F,201508,20160825,20160728,20160830,EXP,,IL-GILEAD-2016-0224992,GILEAD,,50,YR,A,M,Y,84.5,KG,20160830,,OT,IL,IL,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Diarrhoea;Gastrointestinal disorder;Nausea;Osteoporosis;Proteinuria,126045634,OT,,,126045634,1,200802,201201,,,126045634,1,HIV infection
12605983,126059831,1,I,20160719,,20160728,20160728,DIR,,,,,72,YR,,M,N,135,LBS,20160727,N,,US,,SUSTIVA,Blood pressure increased;Drug ineffective;Product substitution issue,126059831,OT,,,126059831,1,20160716,20160722,,,126059831,1,Blood pressure abnormal
12606513,126065131,1,I,,20160721,20160729,20160729,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-060521,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20160729,,PH,US,US,SUSTIVA,Dementia;Gastric tube reconstruction;Pneumonia,126065131,OT,,,,,,,,,126065131,1,Product used for unknown indication
12607402,126074021,1,I,,20140915,20160729,20160729,EXP,,ZA-MYLANLABS-2014M1005294,MYLAN,"LEHLOENYA RJ, ISAACS T, DLAMINI S, MULOIWA R. CUTANEOUS ADVERSE DRUG REACTIONS CAUSED BY FDCAS - WE NEED TO CHARACTERISE AND MANAGE THEM URGENTLY. SMAJ-S-AFR-MED-J 2013; 103(11) 815",,,,,Y,,,20160729,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Erythema annulare;Hepatitis;Palmar erythema;Photosensitivity reaction;Pyrexia;Skin reaction,126074021,OT,,,,,,,,,,,
12607822,126078222,2,F,20160718,20160804,20160729,20160809,EXP,,AM-JNJFOC-20160723655,JANSSEN,,43,YR,A,M,Y,,,20160809,,MD,AM,AM,EFAVIRENZ W/EMTRICITABINE/TENOFOVIR DISOPROXI,Anal incontinence;Condition aggravated;Depressed level of consciousness;Dyspnoea at rest;Fatigue;HIV infection;Treatment noncompliance;Tuberculosis;Urinary incontinence,126078222,OT,,,126078222,1,20140620,20140621,,,126078222,1,Tuberculosis
12607919,126079192,2,F,20160716,20160727,20160729,20160808,EXP,,FR-BAYER-2016-146351,BAYER,,29,YR,A,F,Y,49,KG,20160808,,CN,US,MZ,EFAVIRENZ,Acute respiratory failure;Product use issue,126079192,DE,,,126079192,1,20160716,20160718,,,126079192,1,Respiratory distress
12611183,126111831,1,I,,20160725,20160801,20160801,EXP,,IT-GILEAD-2016-0225417,GILEAD,,39,YR,A,M,Y,118.6,KG,20160801,,MD,IT,IT,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Osteoporosis,126111831,OT,,,126111831,1,20081206,,,,126111831,1,HIV infection
12611620,126116201,1,I,,20160725,20160801,20160801,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-061640,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160801,,CN,US,US,SUSTIVA,Deep vein thrombosis,126116201,OT,,,,,,,,,126116201,1,Deep vein thrombosis
12617512,126175121,1,I,20160125,20160728,20160803,20160803,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-062932,BRISTOL MYERS SQUIBB,,49,YR,,M,Y,81.8,KG,20160803,,OT,ZA,ZA,"EFAVIRENZ;EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",Cognitive disorder,126175121,HO,,,126175121,2,20130425,20160118,,,126175121,1,HIV infection
12624428,126244281,1,I,,20160722,20160805,20160805,EXP,,ZA-LUPIN PHARMACEUTICALS INC.-2016-03399,LUPIN,"MURUNGA E, ANDERSSON M, RENSBURG C. AUTOIMMUNE HEPATITIS: A MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN HIV INFECTED PATIENTS?. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2016;1-5.",42,YR,,F,Y,,,20160805,,MD,ZA,ZA,Efavirenz,Autoimmune hepatitis,126244281,OT,,,,,,,,,126244281,1,HIV infection
12624767,126247672,2,F,2012,20160726,20160805,20160810,EXP,,AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064179,BRISTOL MYERS SQUIBB,,54,YR,,F,Y,,,20160810,,OT,AU,AU,EFAVIRENZ,Progressive multifocal leukoencephalopathy,126247672,OT,,,,,,,,,126247672,1,HIV infection
12624768,126247681,1,I,,20160726,20160805,20160805,EXP,,AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-062054,BRISTOL MYERS SQUIBB,,49,YR,,M,Y,,,20160805,,OT,AU,AU,EFAVIRENZ,Progressive multifocal leukoencephalopathy,126247681,OT,,,,,,,,,126247681,1,HIV infection
12627198,126271981,1,I,,20160725,20160805,20160805,EXP,,US-ASTELLAS-2016US029910,ASTELLAS,,54,YR,,F,Y,,,20160805,,CN,GB,US,EFAVIRENZ,Drug ineffective,126271981,OT,,,126271981,1,201202,,,,126271981,1,Fungal infection
12627469,126274691,1,I,20160513,20160728,20160805,20160805,EXP,,AR-GILEAD-2016-0226029,GILEAD,,42,YR,A,M,Y,93,KG,20160805,,OT,AR,AR,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Intervertebral disc protrusion,126274691,HO,,,126274691,1,20100713,,,,126274691,1,HIV infection
12628089,126280891,1,I,,20160725,20160808,20160808,EXP,,IN-AUROBINDO-AUR-APL-2016-09913,AUROBINDO,"JOSE SK, ET AL.. ANTIVIRALS : ERYTHEMA ELEVATUM DIUTINUM: CASE REPORT. REACTIONS WEEKLY. 2016;1611:26",,,,,Y,,,20160806,,OT,IN,IN,Efavirenz,Cough;Dyspnoea;Erythema;Erythema elevatum diutinum;Fatigue;Nodule;Papule;Skin lesion;Treatment failure;Weight decreased,126280891,OT,,,,,,,,,126280891,1,HIV infection
12636580,126365801,1,I,,20160801,20160809,20160809,EXP,,US-BMSGILMSD-2016-0226741,GILEAD,,,,A,M,Y,,,20160809,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Accident;Bone density abnormal;Meniscus injury;Rib fracture,126365801,OT,,,,,,,,,126365801,1,Product used for unknown indication
12638646,126386461,1,I,,20160805,20160809,20160809,EXP,,GB-BMSGILMSD-2016-0227025,GILEAD,,,,,M,Y,,,20160809,,CN,GB,GB,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Myocardial infarction,126386461,HO,,,,,,,,,126386461,1,HIV infection
12638946,126389461,1,I,20160718,20160804,20160809,20160809,EXP,,AR-GILEAD-2016-0226961,GILEAD,,45,YR,A,M,Y,85,KG,20160809,,MD,AR,AR,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Enteritis,126389461,HO,,,126389461,1,20101122,,,,126389461,1,HIV infection
12642922,126429223,3,F,,20160802,20160811,20160817,EXP,,US-CIPLA LTD.-2016US17002,CIPLA,,,,,,Y,,,20160817,,OT,US,US,Efavirenz,Acute kidney injury;Drug interaction;Fall;Nephropathy toxic;Renal tubular necrosis,126429223,HO,,,,,,,,,126429223,1,HIV infection
12647261,126472611,1,I,,20160803,20160812,20160812,EXP,,TH-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064630,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20160812,,OT,TH,TH,EFAVIRENZ,Guillain-Barre syndrome,126472611,HO,,,,,,,,,126472611,1,Acute HIV infection
12649796,126497962,2,F,2007,20160812,20160812,20160819,EXP,,US-GILEAD-2016-0227748,GILEAD,,56,YR,A,F,Y,,,20160819,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Loss of consciousness;Road traffic accident;Seizure;Spinal cord injury,126497962,OT,,,,,,,,,126497962,1,Product used for unknown indication
12655548,126555482,2,F,,20160817,20160816,20160819,EXP,,US-GALDERMA-US16005571,GALDERMA,AL-HALAWANI M. IRISH JOURNAL OF MEDICAL SCIENCE. SPHINGOMONAS PAUCIMOBILIS BACTEREMIA IN AN HIV AND HEPATITIS C CO-INFECTED PATIENT. 2016;185(3):749-751.,31,YR,,M,Y,,,20160819,,MD,US,US,EFAVIRENZ,Anaphylactic reaction,126555482,OT,,,,,,,,,126555482,1,Product used for unknown indication
12657071,126570711,1,I,20150210,20160715,20160816,20160816,EXP,,US-GILEAD-2016-0224170,GILEAD,,52,YR,A,M,Y,75.28,KG,20160816,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Renal failure,126570711,OT,,,126570711,3,20140514,20160314,,,126570711,1,HIV infection
12657550,126575502,2,F,,20160921,20160816,20160924,EXP,,US-009507513-1608USA007071,MERCK,,,,,M,Y,,,20160924,,MD,US,US,EFAVIRENZ,Nephrolithiasis;Obstructive nephropathy;Renal failure,126575502,DS,,,126575502,1,2014,20160810,,,126575502,1,HIV infection
12660383,126603832,2,F,20160728,20160914,20160817,20160920,EXP,,ZW-GILEAD-2016-0228706,GILEAD,,52,YR,A,M,Y,,,20160920,,OT,ZW,ZW,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Anaemia;Hyponatraemia,126603832,HO,,,126603832,1,20150305,20160728,,,126603832,1,Kaposi's sarcoma
12662266,126622662,2,F,20160617,20160926,20160817,20160928,EXP,,BR-GILEAD-2016-0228623,GILEAD,,74,YR,E,F,Y,67.1,KG,20160928,,MD,BR,BR,EFAVIRENZ,Sepsis,126622662,DE,,,126622662,1,20130617,20160502,,,126622662,1,HIV infection
12662286,126622862,2,F,20160601,20160916,20160817,20160926,EXP,,BR-GILEAD-2016-0228729,GILEAD,,74,YR,E,F,Y,67.1,KG,20160926,,MD,BR,BR,EFAVIRENZ,Diabetes mellitus,126622862,OT,,,126622862,1,20130617,20160502,,,126622862,1,HIV infection
12664189,126641891,1,I,,20160809,20160818,20160818,EXP,,CH-GLAXOSMITHKLINE-CH2016GSK119198,GLAXOSMITHKLINE,"CALMY A, VAN DELDEN C, GIOSTRA E, JUNET C, BRANDT LR, YERLY S ET AL. HIV-POSITIVE-TO-HIV-POSITIVE LIVER TRANSPLANTATION. AMERICAN JOURNAL OF TRANSPLANTATION. 2016;16:2473-2478",53,YR,,M,Y,,,20160818,,OT,CH,CH,EFAVIRENZ,Antiviral drug level above therapeutic;Drug level decreased;Drug resistance;Pathogen resistance;Viral mutation identified,126641891,OT,,,126641891,1,1997,2001,,,126641891,1,HIV infection
12664221,126642211,1,I,,20160809,20160818,20160818,EXP,,CH-VIIV HEALTHCARE LIMITED-CH2016GSK119198,VIIV,"CALMY A, VAN DELDEN C, GIOSTRA E, JUNET C, BRANDT LR, YERLY S ET AL. HIV-POSITIVE-TO-HIV-POSITIVE LIVER TRANSPLANTATION. AMERICAN JOURNAL OF TRANSPLANTATION. 2016;16:2473-2478",53,YR,,M,Y,,,20160818,,OT,CH,CH,EFAVIRENZ,Antiviral drug level above therapeutic;Drug level decreased;Drug resistance;Pathogen resistance;Viral mutation identified,126642211,OT,,,126642211,1,1997,2001,,,126642211,1,HIV infection
12665990,126659901,1,I,,20160809,20160818,20160818,EXP,,GB-GILEAD-2016-0228639,GILEAD,,,,,M,Y,,,20160818,,OT,GB,GB,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Myocardial infarction,126659901,OT,,,,,,,,,126659901,1,HIV infection
12665997,126659972,2,F,20160305,20160906,20160818,20160914,EXP,,CN-GILEAD-2016-0229003,GILEAD,,52,YR,A,M,Y,,,20160914,,OT,CN,CN,EFAVIRENZ,Drug-induced liver injury;Hepatic function abnormal;Rash,126659972,OT,,,126659972,1,20160125,20160311,,,126659972,1,HIV infection
12668385,126683852,2,F,20150720,20160921,20160819,20160930,EXP,,ZA-GILEAD-2016-0229579,GILEAD,,33,YR,A,F,Y,51.5,KG,20160930,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Caesarean section;Maternal exposure during pregnancy,126683852,OT,,,126683852,1,20150720,,,,126683852,1,HIV infection
12668500,126685002,2,F,20151129,20160905,20160819,20160913,EXP,,ZA-GILEAD-2016-0229638,GILEAD,,74,YR,E,M,Y,,,20160913,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Death,126685002,HO,,,126685002,1,20141006,,,,126685002,1,Prophylaxis against HIV infection
12668501,126685012,2,F,20130211,20160921,20160819,20160928,EXP,,ZA-GILEAD-2016-0229582,GILEAD,,27,YR,A,F,Y,73.9,KG,20160928,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Caesarean section;Exposure during pregnancy;Normal newborn,126685012,OT,,,126685012,1,20130702,,,,126685012,1,HIV infection
12668506,126685062,2,F,20150327,20160905,20160819,20160913,EXP,,ZA-GILEAD-2016-0229583,GILEAD,,64,YR,A,F,Y,,,20160913,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Cervix carcinoma,126685062,OT,,,126685062,1,20130925,,,,126685062,1,HIV infection
12668511,126685112,2,F,,20160905,20160819,20160913,EXP,,ZA-GILEAD-2016-0229538,GILEAD,,,,,F,Y,45.3,KG,20160913,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Cervix carcinoma,126685112,DE,,,126685112,1,20131122,,,,126685112,1,HIV infection
12668514,126685142,2,F,20130505,20160921,20160819,20160928,EXP,,ZA-GILEAD-2016-0229633,GILEAD,,22,YR,A,F,Y,70.5,KG,20160928,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abortion spontaneous;Maternal exposure during pregnancy;Pregnancy,126685142,OT,,,126685142,1,20130702,,,,126685142,1,Antiretroviral therapy
12668516,126685162,2,F,20150606,20160905,20160819,20160913,EXP,,ZA-GILEAD-2016-0229658,GILEAD,,25,YR,A,M,Y,53.3,KG,20160913,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Mental disorder,126685162,HO,,,126685162,1,20150224,,,,126685162,1,HIV infection
12668524,126685244,4,F,20160120,20160914,20160819,20160920,EXP,,ZA-GILEAD-2016-0229611,GILEAD,,58,YR,A,M,Y,43,KG,20160920,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Death;Diabetes mellitus,126685244,DE,,,126685244,1,20130508,,,,126685244,1,Prophylaxis against HIV infection
12668529,126685292,2,F,20150401,20160921,20160819,20160928,EXP,,ZA-GILEAD-2016-0229634,GILEAD,,34,YR,A,F,Y,,,20160928,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abortion spontaneous;Maternal exposure during pregnancy,126685292,OT,,,126685292,1,20150219,,,,126685292,1,HIV infection
12668544,126685442,2,F,20150702,20160905,20160819,20160914,EXP,,ZA-GILEAD-2016-0229645,GILEAD,,21,YR,A,F,Y,49.3,KG,20160914,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Bipolar disorder,126685442,HO,,,126685442,1,20150612,201507,,,126685442,1,HIV infection
12668547,126685472,2,F,20141204,20160921,20160819,20160929,EXP,,ZA-GILEAD-2016-0229585,GILEAD,,25,YR,A,F,Y,53.1,KG,20160929,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abortion spontaneous;Exposure during pregnancy,126685472,OT,,,126685472,1,20141104,20141107,,,126685472,1,Antiretroviral therapy
12668565,126685652,2,F,20150212,20160905,20160819,20160914,EXP,,ZA-GILEAD-2016-0229742,GILEAD,,60,YR,A,M,Y,170,KG,20160914,,MD,ZA,ZA,EFAVIRENZ;EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Gastroenteritis;Pulmonary tuberculosis;Renal failure,126685652,HO,,,126685652,1,20141009,20150617,,,126685652,1,HIV infection
12668566,126685662,2,F,20150831,20160905,20160819,20160914,EXP,,ZA-GILEAD-2016-0229683,GILEAD,,27,YR,A,M,Y,64.1,KG,20160914,,MD,ZA,ZA,EFAVIRENZ;EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Acute kidney injury;Anaemia,126685662,HO,,,126685662,1,20150625,20150901,,,126685662,1,HIV infection
12668567,126685673,3,F,20150827,20160908,20160819,20160920,EXP,,ZA-GILEAD-2016-0229697,GILEAD,,32,YR,A,F,Y,57,KG,20160920,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Hypochromic anaemia,126685673,OT,,,126685673,1,20150519,,,,126685673,1,HIV infection
12668569,126685691,1,I,20150413,20160804,20160819,20160819,EXP,,ZA-GILEAD-2016-0229648,GILEAD,,,,,M,Y,,,20160819,,MD,ZA,ZA,EFAVIRENZ;EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Death,126685691,DE,,,126685691,2,20070622,20141125,,,126685691,1,Product used for unknown indication
12668570,126685702,2,F,20130206,20160921,20160819,20160930,EXP,,ZA-GILEAD-2016-0229584,GILEAD,,21,YR,A,F,Y,,,20160930,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Death of relative;Exposure during pregnancy;Premature delivery,126685702,OT,,,126685702,1,20121008,,,,126685702,1,HIV infection
12668664,126686642,2,F,20160122,20160905,20160819,20160914,EXP,,ZA-GILEAD-2016-0229613,GILEAD,,54,YR,A,F,Y,89.9,KG,20160914,,MD,ZA,ZA,EFAVIRENZ;EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Renal failure,126686642,OT,,,126686642,1,20130503,20160122,,,126686642,1,HIV infection
12670349,126703491,1,I,,20160809,20160822,20160822,EXP,,US-GLAXOSMITHKLINE-US2016GSK120368,GLAXOSMITHKLINE,"LAZENBY GB, MMEJE O, FISHER BM, WEINBERG A, AARON EK, KEATING M ET AL. ANTIRETROVIRAL RESISTANCE AND PREGNANCY CHARACTERISTICS OF WOMEN WITH PERINATAL AND NONPERINATAL HIV INFECTION. INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY. 2016;2016:1-8",,,,F,Y,,,20160822,,OT,US,US,Efavirenz,Drug resistance;Exposure during pregnancy;Pathogen resistance,126703491,OT,,,,,,,,,126703491,1,Antiretroviral therapy
12670413,126704131,1,I,,20160809,20160822,20160822,EXP,,US-VIIV HEALTHCARE LIMITED-US2016GSK120368,VIIV,"LAZENBY GB, MMEJE O, FISHER BM, WEINBERG A, AARON EK, KEATING M ET AL. ANTIRETROVIRAL RESISTANCE AND PREGNANCY CHARACTERISTICS OF WOMEN WITH PERINATAL AND NONPERINATAL HIV INFECTION. INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY. 2016;2016:1-8",,,,F,Y,,,20160822,,OT,US,US,Efavirenz,Drug resistance;Exposure during pregnancy;Pathogen resistance,126704131,OT,,,,,,,,,126704131,1,Antiretroviral therapy
12671099,126710991,1,I,201510,20160810,20160822,20160822,EXP,,CH-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-068710,BRISTOL MYERS SQUIBB,,53,YR,,M,Y,,,20160822,,OT,CH,CH,EFAVIRENZ,Hepatic cirrhosis;Hepatitis B;Hepatitis D;Hepatocellular injury;Liver transplant,126710991,OT,,,,,,,,,126710991,1,HIV infection
12671717,126717172,2,F,20150129,20160905,20160822,20160915,EXP,,ZA-GLAXOSMITHKLINE-ZA2016JPN120644,GLAXOSMITHKLINE,,43,YR,,F,Y,,,20160915,,MD,ZA,ZA,EFAVIRENZ + EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE;Efavirenz,Gamma-glutamyltransferase increased,126717172,OT,,,126717172,1,20110825,20150209,,,126717172,1,HIV infection
12671944,126719442,2,F,20150129,20160905,20160822,20160915,EXP,,ZA-VIIV HEALTHCARE LIMITED-ZA2016JPN120644,VIIV,,43,YR,,F,Y,,,20160915,,MD,ZA,ZA,EFAVIRENZ + EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE;Efavirenz,Gamma-glutamyltransferase increased,126719442,OT,,,126719442,1,20110825,20150209,,,126719442,1,HIV infection
12674657,126746572,2,F,20130109,20160921,20160822,20160929,EXP,,ZA-GILEAD-2016-0229567,GILEAD,,29,YR,A,F,Y,77.9,KG,20160929,,MD,ZA,ZA,EFAVIRENZ;EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Caesarean section;Exposure during pregnancy;Normal newborn,126746572,OT,,,126746572,1,20120606,20120606,,,126746572,1,HIV infection
12675283,126752832,2,F,20150727,20160905,20160822,20160913,EXP,,ZA-GILEAD-2016-0229615,GILEAD,,53,YR,A,F,Y,,,20160913,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Death;Dyspnoea;Gamma-glutamyltransferase increased;Headache,126752832,OT,,,126752832,1,20150625,,,,126752832,1,Antiretroviral therapy
12676060,126760601,1,I,,20160809,20160823,20160823,EXP,,ZA-AUROBINDO-AUR-APL-2016-10792,AUROBINDO,,42,YR,,F,Y,,,20160823,,OT,ZA,ZA,Efavirenz,Autoimmune hepatitis;Hepatic enzyme abnormal;Immune reconstitution inflammatory syndrome,126760601,OT,,,,,,,,,126760601,1,HIV infection
12676420,126764202,2,F,20130109,20160921,20160823,20160930,EXP,,ZA-VIIV HEALTHCARE LIMITED-ZA2016121903,VIIV,,29,YR,,F,Y,77.9,KG,20160930,,MD,ZA,ZA,EFAVIRENZ + EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE;Efavirenz,Caesarean section;Exposure during pregnancy;Normal newborn,126764202,OT,,,126764202,1,20110917,20120606,,,126764202,1,HIV infection
12676465,126764652,2,F,20130109,20160921,20160823,20160930,EXP,,ZA-GLAXOSMITHKLINE-ZA2016121903,GLAXOSMITHKLINE,,29,YR,,F,Y,77.9,KG,20160930,,MD,ZA,ZA,EFAVIRENZ + EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE;Efavirenz,Caesarean section;Exposure during pregnancy;Normal newborn,126764652,OT,,,126764652,1,20110917,20120606,,,126764652,1,HIV infection
12677080,126770802,2,F,,20160912,20160823,20160919,EXP,,ZA-GILEAD-2016-0229581,GILEAD,,31,YR,A,F,Y,74.12,KG,20160919,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abortion spontaneous;Exposure during pregnancy,126770802,OT,,,126770802,1,20141104,,,,126770802,1,Antiretroviral therapy
12677474,126774741,1,I,,20160810,20160823,20160823,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069628,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160823,,OT,ES,ES,EFAVIRENZ,Neurotoxicity,126774741,OT,,,,,,,,,126774741,1,HIV infection
12677475,126774751,1,I,,20160810,20160823,20160823,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069630,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160823,,OT,ES,ES,EFAVIRENZ,Neurotoxicity,126774751,OT,,,,,,,,,126774751,1,HIV infection
12677489,126774891,1,I,,20160810,20160823,20160823,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069629,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160823,,OT,ES,ES,EFAVIRENZ,Neurotoxicity,126774891,OT,,,,,,,,,126774891,1,HIV infection
12677501,126775011,1,I,,20160810,20160823,20160823,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069631,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160823,,OT,ES,ES,EFAVIRENZ,Neurotoxicity,126775011,OT,,,,,,,,,126775011,1,HIV infection
12677880,126778801,1,I,,20160817,20160823,20160823,EXP,,US-GILEAD-2016-0229315,GILEAD,,38,YR,A,M,Y,,,20160823,,PH,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Chest pain,126778801,HO,,,,,,,,,126778801,1,HIV infection
12678578,126785781,1,I,,20160815,20160823,20160823,EXP,,GB-BMSGILMSD-2016-0229406,GILEAD,"HAMZAH L, TIRABOSCH J, IVESON H, TOBY M, MANT C, CASON J, BURLING K, WANDOLO E, JENDRULEK I, TAYLOR C, IBRAHIM F, KULASEGARAM R, TEAGUE A, POST F, FOX J. EFFECTS ON VITAMIN D, BONE AND THE KIDNEY OF SWITCHING FROM FIXED-DOSE TENOFOVIR DISOPROXIL FUMARATE/EMTRICITABINE/EFAVIRENZ TO DARUNAVIR/RITONAVIR MONOTHERAPY: A RANDOMIZED, CONTROLLED TRIAL (MIDAS). ANTIVIRAL THERAPY.. 2016;21:287-296",,,A,,Y,,,20160823,,OT,GB,GB,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Hyperparathyroidism secondary,126785781,OT,,,,,,,,,126785781,1,HIV infection
12678598,126785981,1,I,20130503,20160804,20160823,20160823,EXP,,ZA-GILEAD-2016-0229684,GILEAD,,31,YR,A,F,Y,,,20160823,,OT,ZA,ZA,EFAVIRENZ;EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Caesarean section;Exposure during pregnancy;Normal newborn,126785981,OT,,,126785981,2,20110317,20130826,,,126785981,1,HIV infection
12678862,126788621,1,I,,20160810,20160824,20160824,EXP,,KR-CIPLA LTD.-2016KR17421,CIPLA,,,,,,Y,,,20160824,,OT,KR,KR,Efavirenz,Somnolence,126788621,OT,,,,,,,,,126788621,1,HIV infection
12679329,126793291,1,I,20011205,20020522,20160824,20160824,EXP,,SN-BRISTOL-MYERS SQUIBB COMPANY-11884095,BRISTOL MYERS SQUIBB,,34,YR,,F,Y,,,20160824,,OT,US,SN,EFAVIRENZ,Pregnancy;Tuberculosis,126793291,OT,,,126793291,1,20000118,20010507,,,126793291,1,HIV infection
12679716,126797161,1,I,20150913,20160804,20160824,20160824,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069195,BRISTOL MYERS SQUIBB,,56,YR,,F,Y,,,20160824,,OT,ZA,ZA,EFAVIRENZ,Diabetes mellitus inadequate control;Haematemesis,126797161,HO,,,126797161,1,20150217,20150913,,,126797161,1,HIV infection
12680629,126806292,2,F,20160814,20160910,20160824,20160916,EXP,,ZA-JNJFOC-20160813484,JANSSEN,,37,YR,A,M,Y,64.7,KG,20160916,,MD,ZA,ZA,EFAVIRENZ W/EMTRICITABINE/TENOFOVIR DISOPROXI,Angioedema,126806292,OT,,,126806292,1,2016,2016,,,126806292,1,Tuberculosis
12682077,126820772,2,F,20150413,20160804,20160824,20160831,EXP,,ZA-GILEAD-2016-0230242,GILEAD,,47,YR,A,F,Y,,,20160831,,OT,ZA,ZA,EFAVIRENZ,Anaemia,126820772,LT,,,126820772,1,20140611,,,,126820772,1,HIV infection
12682573,126825731,1,I,200906,20160810,20160825,20160825,EXP,,TH-CIPLA LTD.-2016TH17435,CIPLA,,,,,,Y,,,20160825,,OT,TH,TH,Efavirenz,Anaemia;Death;Leishmaniasis;Meningitis cryptococcal;Rash;Seizure;Weight increased,126825731,DE,,,,,,,,,126825731,1,HIV infection
12682848,126828481,1,I,,20160812,20160825,20160825,EXP,,JP-CIPLA LTD.-2016JP17498,CIPLA,,,,,,Y,,,20160825,,OT,JP,JP,Efavirenz,Hyperlipidaemia,126828481,OT,,,,,,,,,126828481,1,HIV infection
12682853,126828531,1,I,,20160812,20160825,20160825,EXP,,JP-CIPLA LTD.-2016JP17499,CIPLA,,,,,,Y,,,20160825,,OT,JP,JP,Efavirenz,Hyperlipidaemia,126828531,OT,,,,,,,,,126828531,1,HIV infection
12685353,126853533,3,F,20140810,20160901,20160825,20160908,EXP,,IT-GILEAD-2016-0230054,GILEAD,,51,YR,A,F,Y,48,KG,20160908,,MD,IT,IT,EFAVIRENZ,Depression;Diabetes mellitus;Foot fracture;Hypercholesterolaemia;Hypertension;Insomnia;Nightmare;Osteoporosis;Vitamin D deficiency,126853533,OT,,,126853533,1,20120627,20141110,,,126853533,1,HIV infection
12685521,126855211,1,I,,20160817,20160825,20160825,EXP,,MX-GILEAD-2016-0229456,GILEAD,CRUZ-RODRIGUEZ A. TENOFOVIR AND ITS RELATION TO OSTEOPOROSIS IN HIV PATIENTS. MED INT M?X. 2015;31:150-154,,,A,,Y,,,20160825,,OT,MX,MX,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Osteoporosis,126855211,OT,,,,,,,,,126855211,1,HIV infection
12688243,126882431,1,I,,20160812,20160826,20160826,EXP,,IT-CIPLA LTD.-2016IT17540,CIPLA,,,,,,Y,,,20160826,,OT,IT,IT,Efavirenz,Diarrhoea;Hepatitis B;Interstitial lung disease;Mycobacterium avium complex infection;Oesophageal candidiasis;Rash;Treatment noncompliance;Virologic failure,126882431,OT,,,126882431,1,200205,200304,,,126882431,1,Antiretroviral therapy
12689073,126890731,1,I,,20160812,20160826,20160826,EXP,,TH-CIPLA LTD.-2016TH17523,CIPLA,,,,,,Y,,,20160826,,OT,AU,TH,Efavirenz,Hepatitis B;Jaundice;Nausea,126890731,OT,,,,,,,,,126890731,1,Hepatitis B
12689203,126892031,1,I,,20160812,20160826,20160826,EXP,,TH-CIPLA LTD.-2016TH17522,CIPLA,,,,,,Y,,,20160826,,OT,AU,TH,Efavirenz,Hepatic failure;Hepatitis B,126892031,DE,,,,,,,,,126892031,1,Hepatitis B
12689480,126894802,2,F,20140810,20160901,20160826,20160909,EXP,,IT-GLAXOSMITHKLINE-IT2016123953,GLAXOSMITHKLINE,,51,YR,,F,Y,48,KG,20160909,,MD,IT,IT,EFAVIRENZ,Blood alkaline phosphatase increased;Depression;Diabetes mellitus;Foot fracture;Hypercholesterolaemia;Hypertension;Insomnia;Nightmare;Osteoporosis;Traumatic fracture;Vitamin D deficiency,126894802,OT,,,126894802,1,20120627,20141110,,,126894802,1,HIV infection
12689495,126894951,1,I,,20111205,20160826,20160826,EXP,,US-ROCHE-1022589,ROCHE,", HAZRA R, VAN DYKE R, YILDIRIM C, CRAIN M, SEAGE G, CIVITELLO L, ELLIS A, BUTLER L AND RICH K ANTIRETROVIRAL EXPOSURE DURING PREGNANCY AND ADVERSE OUTCOMES IN HIV-EXPOSED UNINFECTED INFANTS AND CHILDREN USING A TRIGGER-BASED DESIGN. AIDS 2016;30 (1):133-144.",,,N,,Y,,,20160826,,MD,US,US,EFAVIRENZ,Blood lactic acid increased;Dyslipidaemia;Foetal exposure during pregnancy;Growth retardation;Insulin resistance;Left ventricular dysfunction;Low birth weight baby;Nervous system disorder;Obesity;Ventricular hypertrophy,126894951,OT,,,,,,,,,126894951,1,Product used for unknown indication
12689614,126896143,3,F,20140810,20160901,20160826,20160909,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016123953,VIIV,,51,YR,,F,Y,48,KG,20160909,,MD,IT,IT,EFAVIRENZ,Blood alkaline phosphatase increased;Depression;Diabetes mellitus;Foot fracture;Hypercholesterolaemia;Hypertension;Insomnia;Nightmare;Osteoporosis;Traumatic fracture;Vitamin D deficiency,126896143,OT,,,126896143,1,20120627,20141110,,,126896143,1,HIV infection
12692464,126924641,1,I,201006,20160815,20160829,20160829,EXP,,CA-CIPLA LTD.-2016CA17600,CIPLA,"NACCARATO M, YOONG D, GOUGH K. A POTENTIAL DRUG-HERBAL INTERACTION BETWEEN GINKGO BILOBA AND EFAVIRENZ. JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PHYSICIANS IN AIDS CARE. 2012;11 (2):98 TO 100",,,,,Y,,,20160829,,OT,CA,CA,Efavirenz,Drug interaction;Virologic failure,126924641,OT,,,,,,,,,126924641,1,HIV infection
12692497,126924971,1,I,,20160815,20160829,20160829,EXP,,IT-CIPLA LTD.-2016IT17591,CIPLA,,,,,,Y,,,20160829,,OT,IT,IT,Efavirenz,Treatment noncompliance,126924971,OT,,,,,,,,,126924971,1,Antiretroviral therapy
12692700,126927001,1,I,,20130416,20160829,20160829,EXP,,ZA-CIPLA LTD.-2013US00458,CIPLA,"STEFAN DC, DIPPENAAR A, DE BRUIN G, UYS R, VAN TOORN R. CHALLENGES TO TREATMENT OF LEUKEMIA IN HIV-POSITIVE CHILDREN. JOURNAL OF TROPICAL PEDIATRICS. 2012;58 (6):521 TO 522",,,,,Y,,,20160829,,OT,ZA,ZA,Efavirenz,Anal incontinence;Hypersensitivity;Leukaemic infiltration;Paraplegia;Systemic infection;Urinary incontinence,126927001,OT,,,,,,,,,126927001,1,HIV infection
12692726,126927261,1,I,,20160817,20160829,20160829,EXP,,TH-CIPLA LTD.-2016TH17685,CIPLA,,,,,,Y,,,20160829,,OT,TH,TH,Efavirenz,Rash maculo-papular,126927261,OT,,,,,,,,,126927261,1,HIV infection
12692732,126927321,1,I,,20160817,20160829,20160829,EXP,,IT-CIPLA LTD.-2016IT17679,CIPLA,"MANFREDI R, PIERGENTILI B, MARINACCI G, CALZA L. ATYPICAL PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN HIV WITH A HIGH CD4 COUNT: THE USE OF MAGNETIC RESONANCE IMAGING PLUS SPECTROMETRY STUDIES. INTERNATIONAL JOURNAL OF STD + AIDS. 2012;23:E35 TO E38",,,,,Y,,,20160829,,OT,IT,IT,Efavirenz,Condition aggravated;Respiratory failure,126927321,DE,,,,,,,,,126927321,1,HIV infection
12693020,126930201,1,I,,20140616,20160829,20160829,EXP,,US-CIPLA LTD.-2014US00582,CIPLA,"LUNI FK, KHAN AR, PRASHAR R, VETTETH S, DUGGAN JM. FANCONI SYNDROME AND ANTIRETROVIRALS: IT IS NEVER TOO LATE. AMERICAN JOURNAL OF THERAPEUTICS. 2016;23:E558 TO E560",,,,,Y,,,20160829,,OT,US,US,TENOFOVIR/EMTRICITABINE/EFAVIRENZ,Acute kidney injury;Asthenia;Depression;Diarrhoea;Fanconi syndrome acquired;Hypotension;Multiple organ dysfunction syndrome;Nausea;Respiratory failure;Staphylococcal bacteraemia;Subcutaneous abscess;Treatment noncompliance;Vomiting,126930201,OT,,,126930201,1,1996,2006,,,126930201,1,Antiretroviral therapy
12694331,126943311,1,I,19990702,19990705,20160829,20160829,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-1999SUS0681,BRISTOL MYERS SQUIBB,,33,YR,,F,Y,,,20160829,,OT,ES,ES,EFAVIRENZ;EFAVIRENZ W/EMTRICITABINE/TENOFOVIR DISOPROXI,Affect lability;Aggression;Disinhibition;Irritability;Judgement impaired;Mania;Overdose;Psychotic disorder;Suicide attempt;Thinking abnormal,126943311,HO,,,126943311,1,19990630,19990703,,,126943311,1,HIV infection
12695546,126955462,2,F,20140916,20160921,20160829,20160930,EXP,,ZA-GILEAD-2016-0229667,GILEAD,,31,YR,A,F,Y,45.6,KG,20160930,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Breast feeding;Caesarean section;Exposure during pregnancy;Normal newborn,126955462,OT,,,126955462,2,20140829,,,,126955462,1,HIV infection
12695989,126959892,2,F,20150118,20160921,20160829,20160928,EXP,,ZA-GILEAD-2016-0229556,GILEAD,,40,YR,A,F,Y,61.1,KG,20160928,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Caesarean section;Exposure during pregnancy;Normal newborn,126959892,OT,,,126959892,1,20130604,,,,126959892,1,HIV infection
12696616,126966162,2,F,20160313,20160822,20160830,20160909,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-070753,BRISTOL MYERS SQUIBB,,30,YR,,M,Y,66,KG,20160909,,CN,CN,CN,EFAVIRENZ,Rash,126966162,HO,,,126966162,1,20160308,20160331,,,126966162,1,Acquired immunodeficiency syndrome
12697012,126970121,1,I,20160223,20160822,20160830,20160830,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-070749,BRISTOL MYERS SQUIBB,,77,YR,,F,Y,,,20160830,,CN,CN,CN,EFAVIRENZ,Abdominal discomfort;Diarrhoea;Nausea,126970121,HO,,,126970121,1,20160203,,,,126970121,1,HIV infection
12700014,127000141,1,I,,20160823,20160830,20160830,EXP,,ZA-BMSGILMSD-2016-0230663,GILEAD,,38,YR,A,M,Y,,,20160830,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Chest pain,127000141,HO,,,,,,,,,127000141,1,Product used for unknown indication
12701254,127012541,1,I,20160623,20160817,20160831,20160831,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-068145,BRISTOL MYERS SQUIBB,,1,DY,,M,Y,2.26,KG,20160831,,OT,BR,BR,EFAVIRENZ,Diarrhoea;Foetal exposure during pregnancy;Jaundice neonatal;Low birth weight baby,127012541,OT,,,127012541,1,20160520,,,,127012541,1,Product used for unknown indication
12702855,127028551,1,I,20130503,20160804,20160831,20160831,EXP,,ZA-VIIV HEALTHCARE LIMITED-ZA2016122522,VIIV,,31,YR,,F,Y,,,20160831,,MD,ZA,ZA,Efavirenz,Caesarean section;Exposure during pregnancy;Normal newborn,127028551,OT,,,127028551,2,20110317,20130826,,,127028551,1,HIV infection
12702858,127028581,1,I,,20160823,20160831,20160831,EXP,,MZ-VIIV HEALTHCARE LIMITED-MZ2016GSK126089,VIIV,"WINGI O, CAPPELLESSO R, AREGO R, CUPPINI E, MUHELO A, PUTOTO G ET AL. FAILED CONSERVATIVE MANAGEMENT OF A CASE OF APLASIA CUTIS CONGENITA IN A LOW-INCOME COUNTRY. CLINICAL CASE REPORTS. 2016;4 (8):756-758",,,N,F,Y,,,20160831,,OT,MZ,MZ,Efavirenz,Abdominal distension;Aplasia cutis congenita;Condition aggravated;Contraindication to medical treatment;Fistula;Foetal exposure during pregnancy;Irritability;Laceration;Necrosis;Pain;Selective eating disorder;Skin disorder;Skin exfoliation;Skin lesion;Skin necrosis;Treatment failure;Weight decreased,127028581,OT,,,,,,,,,127028581,1,Antiretroviral therapy
12702962,127029621,1,I,,20160823,20160831,20160831,EXP,,MZ-GLAXOSMITHKLINE-MZ2016GSK126089,GLAXOSMITHKLINE,"WINGI O, CAPPELLESSO R, AREGO R, CUPPINI E, MUHELO A, PUTOTO G ET AL. FAILED CONSERVATIVE MANAGEMENT OF A CASE OF APLASIA CUTIS CONGENITA IN A LOW-INCOME COUNTRY. CLINICAL CASE REPORTS. 2016;4 (8):756-758",,,N,F,Y,,,20160831,,OT,MZ,MZ,Efavirenz,Abdominal distension;Aplasia cutis congenita;Condition aggravated;Contraindication to medical treatment;Fistula;Foetal exposure during pregnancy;Irritability;Laceration;Necrosis;Pain;Selective eating disorder;Skin disorder;Skin exfoliation;Skin lesion;Skin necrosis;Treatment failure;Weight decreased,127029621,OT,,,,,,,,,127029621,1,Antiretroviral therapy
12703039,127030391,1,I,20130503,20160804,20160831,20160831,EXP,,ZA-GLAXOSMITHKLINE-ZA2016122522,GLAXOSMITHKLINE,,31,YR,,F,Y,,,20160831,,MD,ZA,ZA,Efavirenz,Caesarean section;Exposure during pregnancy;Normal newborn,127030391,OT,,,127030391,2,20110317,20130826,,,127030391,1,HIV infection
12704488,127044881,1,I,,20160824,20160831,20160831,EXP,,US-009507513-1608USA013306,MERCK,,1,DY,,M,Y,,,20160831,,CN,US,US,EFAVIRENZ,Chordee;Foetal exposure during pregnancy;Hypospadias,127044881,CA,,,,,,,,,127044881,1,Product used for unknown indication
12705608,127056082,2,F,20150413,20160901,20160901,20160906,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069259,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20160906,,OT,ZA,ZA,"EFAVIRENZ;EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",Death,127056082,OT,,,127056082,1,20070622,20141125,,,127056082,1,HIV infection
12708238,127082381,1,I,20160802,20160804,20160901,20160901,EXP,,UG-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065651,BRISTOL MYERS SQUIBB,,37,YR,,M,Y,49,KG,20160901,,CN,UG,UG,"EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",Acute kidney injury;Anaemia;Dehydration,127082381,LT,,,127082381,2,20140319,20160802,,,127082381,1,Kaposi's sarcoma AIDS related
12708298,127082981,1,I,,20160826,20160901,20160901,EXP,,NL-MYLANLABS-2016M1037070,MYLAN,"SCHERPBIER HJ, TERPSTRA V, PAJKRT D, PUTHAKANIT T, ANANWORANICH J, FOSTER C, ET AL. NONCIRRHOTIC PORTAL HYPERTENSION IN PERINATALLY HIV-INFECTED ADOLESCENTS TREATED WITH DIDANOSINE-CONTAINING ANTIRETROVIRAL REGIMENS IN CHILDHOOD. PEDIATR-INFECT-DIS-J 2016;35(8):E248-E252.",,,,,Y,,,20160901,,MD,NL,NL,EFAVIRENZ,Gastric varices haemorrhage;Non-cirrhotic portal hypertension,127082981,OT,,,,,,,,,127082981,1,Perinatal HIV infection
12713243,127132431,1,I,20160824,20160824,20160902,20160902,EXP,,CN-GILEAD-2016-0231761,GILEAD,,54,YR,A,F,Y,,,20160902,,OT,CN,CN,EFAVIRENZ,Lung infection;Renal disorder,127132431,OT,,,127132431,1,20160223,,,,127132431,1,HIV infection
12716231,127162311,1,I,200208,20021028,20160906,20160906,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-12095063,BRISTOL MYERS SQUIBB,,32,YR,,F,Y,,,20160906,,CN,FR,FR,SUSTIVA,Abortion induced;Abortion spontaneous;Maternal exposure during pregnancy;Twin pregnancy;Vanishing twin syndrome,127162311,OT,,,127162311,1,,20020831,,,127162311,1,HIV infection
12716302,127163021,1,I,20150913,20160804,20160906,20160906,EXP,ZA-ANRS-201500977,ZA-BAYER-2016-166356,BAYER,,56,YR,A,F,Y,,,20160906,,CN,US,ZA,EFAVIRENZ,Diabetes mellitus inadequate control;Haematemesis,127163021,HO,,,127163021,1,20040528,20150913,,,127163021,1,Product used for unknown indication
12717225,127172252,2,F,201408,20160830,20160906,20160908,EXP,,IT-GLAXOSMITHKLINE-IT2016GSK124581,GLAXOSMITHKLINE,,53,YR,,F,Y,50,KG,20160908,,MD,IT,IT,EFAVIRENZ,Depression;Diabetes mellitus;Foot fracture;Hypercholesterolaemia;Hypertension;Insomnia;Nightmare;Osteoporosis;Vitamin D deficiency,127172252,OT,,,127172252,6,20001122,,,,127172252,1,HIV infection
12718236,127182362,2,F,201408,20160830,20160906,20160908,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016GSK124581,VIIV,,53,YR,,F,Y,50,KG,20160908,,MD,IT,IT,EFAVIRENZ,Depression;Diabetes mellitus;Foot fracture;Hypercholesterolaemia;Hypertension;Insomnia;Nightmare;Osteoporosis;Vitamin D deficiency,127182362,OT,,,127182362,6,20001122,,,,127182362,1,HIV infection
12718588,127185881,1,I,2014,20150203,20160906,20160906,EXP,,CH-GILEAD-2016-0217715,GILEAD,,62,YR,A,M,Y,,,20160906,,MD,CH,CH,EFAVIRENZ,Chronic kidney disease;Fanconi syndrome acquired;Osteoporotic fracture;Renal tubular disorder,127185881,OT,,,,,,,,,127185881,1,Chronic hepatitis B
12721148,127211481,1,I,,20160831,20160907,20160907,EXP,,PHHY2016BR123131,NOVARTIS,,63,YR,,M,Y,,,20160907,,MD,BR,BR,EFAVIRENZ,Haemoglobin decreased;Metastases to bone;Metastases to lung;Metastases to lymph nodes,127211481,OT,,,127211481,1,20160507,20160713,,,127211481,1,Metastatic renal cell carcinoma
12721910,127219102,2,F,20140428,20160905,20160907,20160914,EXP,,ZA-GILEAD-2016-0229635,GILEAD,,26,YR,A,F,Y,,,20160914,,OT,ZA,ZA,EFAVIRENZ W/EMTRICITABINE/TENOFOVIR DISOPROXI;EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abortion spontaneous;Exposure during pregnancy,127219102,OT,,,127219102,3,2007,,,,127219102,1,HIV infection
12723364,127233641,1,I,,20160830,20160908,20160908,EXP,,CO-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-073617,BRISTOL MYERS SQUIBB,,60,YR,,M,Y,,,20160908,,OT,CO,CO,EFAVIRENZ,Hepatic cirrhosis,127233641,DE,,,,,,,,,127233641,1,HIV infection
12724292,127242921,1,I,20160803,,20160906,20160906,DIR,,,FDA-CTU,,37,YR,,M,N,49.0,KG,20160818,Y,OT,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DF,Acute kidney injury;Diarrhoea;Dyspnoea;Hyperkalaemia,127242921,LT,127242921,HP,127242921,1,20140319,20140906,,,127242921,1,Chemotherapy
12725431,127254312,2,F,20160819,20160906,20160908,20160914,EXP,,US-BMSGILMSD-2016-0231776,GILEAD,,62,YR,A,M,Y,,,20160914,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Ankle fracture,127254312,OT,,,,,,,,,127254312,1,HIV infection
12727517,127275171,1,I,,20160829,20160909,20160909,EXP,,ES-TEVA-690360ISR,TEVA,,55,YR,,M,Y,,,20160909,,OT,ES,ES,efavirenz,Acute kidney injury;Drug interaction,127275171,HO,,,127275171,1,201310,20140314,,,127275171,1,Hypertension
12727841,127278411,1,I,20160314,20160901,20160909,20160909,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-073055,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160909,,OT,US,US,EFAVIRENZ,Extradural abscess,127278411,OT,,,,,,,,,127278411,1,Antiretroviral therapy
12729803,127298031,1,I,,20160830,20160909,20160909,EXP,,CO-009507513-1609COL004786,MERCK,,60,YR,,M,Y,,,20160909,,CN,US,CO,EFAVIRENZ,Hepatic cirrhosis,127298031,DE,,,,,,,,,127298031,1,HIV infection
12732749,127327492,2,F,20151105,20160908,20160912,20160920,EXP,,ZW-GILEAD-2016-0231809,GILEAD,,33,YR,A,F,Y,75.1,KG,20160920,,OT,ZW,ZW,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abortion spontaneous;Maternal exposure during pregnancy,127327492,OT,,,127327492,1,20151105,20160224,,,127327492,1,Kaposi's sarcoma AIDS related
12733750,127337501,1,I,20140414,20140512,20160912,20160912,EXP,,ZA-GILEAD-2014-0102606,GILEAD,,53,YR,A,M,Y,40.5,KG,20160912,,MD,ZA,ZA,EFAVIRENZ;EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Acute kidney injury;Diarrhoea,127337501,DE,,,127337501,1,20140414,20140414,,,127337501,1,HIV infection
12735992,127359921,1,I,20130109,20160804,20160913,20160913,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069863,BRISTOL MYERS SQUIBB,,29,YR,,F,Y,,,20160913,,CN,FR,ZA,"EFAVIRENZ;EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",Caesarean section;Maternal exposure during pregnancy;Normal newborn,127359921,OT,,,127359921,1,20110917,20120606,,,127359921,1,HIV infection
12740298,127402981,1,I,20140320,20160905,20160913,20160913,EXP,,ZA-GILEAD-2016-0233009,GILEAD,,26,YR,A,F,Y,46.6,KG,20160913,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Gastroenteritis,127402981,HO,,,127402981,1,20120921,,,,127402981,1,HIV infection
12740301,127403011,1,I,20151007,20151016,20160913,20160913,EXP,,UG-GILEAD-2015-0178817,GILEAD,,27,YR,A,M,Y,53,KG,20160913,,MD,UG,UG,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Decreased appetite;Diarrhoea;Gastroenteritis;Leukoplakia;Malaise;Oral candidiasis;Vomiting,127403011,HO,,,127403011,1,20140207,20151006,,,127403011,1,HIV infection
12740378,127403782,2,F,20140527,20160922,20160913,20160929,EXP,,ZA-GILEAD-2016-0232542,GILEAD,,43,YR,A,M,Y,,,20160929,,MD,ZA,ZA,EFAVIRENZ;EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Cholecystitis acute;Gamma-glutamyltransferase increased;Hepatic enzyme abnormal;Physical assault;Pulmonary tuberculosis,127403782,OT,,,127403782,1,20130417,,,,127403782,1,HIV infection
12740444,127404441,1,I,20150810,20160804,20160913,20160913,EXP,,ZA-GILEAD-2016-0229604,GILEAD,,51,YR,A,M,Y,,,20160913,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Confusional state;Pulmonary tuberculosis,127404441,HO,,,127404441,1,2013,,,,127404441,1,HIV infection
12741534,127415342,2,F,,20160919,20160914,20160921,EXP,,CA-ROCHE-1829817,ROCHE,,,,,M,Y,,,20160921,,OT,CA,CA,SUSTIVA,Depression;Drug interaction,127415342,OT,,,,,,,,,127415342,1,Product used for unknown indication
12741772,127417722,2,F,20140527,20160922,20160914,20160930,EXP,,ZA-GLAXOSMITHKLINE-ZA2016133779,GLAXOSMITHKLINE,,43,YR,,M,Y,,,20160930,,MD,ZA,ZA,EFAVIRENZ + EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE;Efavirenz,Cholecystitis acute;Gamma-glutamyltransferase increased;Hepatic enzyme abnormal;Physical assault;Pulmonary tuberculosis,127417722,DE,,,127417722,1,20110316,,,,127417722,1,HIV infection
12741850,127418501,1,I,,20160830,20160914,20160914,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-072133,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20160914,,CN,US,US,SUSTIVA,Feeling abnormal,,,,,,,,,,,127418501,1,HIV infection
12741889,127418892,2,F,20140527,20160922,20160914,20160930,EXP,,ZA-VIIV HEALTHCARE LIMITED-ZA2016133779,VIIV,,43,YR,,M,Y,,,20160930,,MD,ZA,ZA,EFAVIRENZ + EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE;Efavirenz,Cholecystitis acute;Gamma-glutamyltransferase increased;Hepatic enzyme abnormal;Physical assault;Pulmonary tuberculosis,127418892,DE,,,127418892,1,20110316,,,,127418892,1,HIV infection
12742870,127428702,2,F,20140519,20160905,20160914,20160916,EXP,,ZA-GILEAD-2016-0232440,GILEAD,,59,YR,A,M,Y,50.7,KG,20160916,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Gastroenteritis;Pulmonary tuberculosis,127428702,OT,,,,,,,,,127428702,1,HIV infection
12742894,127428941,1,I,,20160907,20160914,20160914,EXP,,MZ-MYLANLABS-2016M1039032,MYLAN,"WINGI O, CAPPELLESSO R, AREGO R, CUPPINI E, MUHELO A, PUTOTO G, ET AL. FAILED CONSERVATIVE MANAGEMENT OF A CASE OF APLASIA CUTIS CONGENITA IN A LOW-INCOME COUNTRY. CLIN-CASE-REP 2016;4(8):756-758.",,,,,Y,,,20160914,,OT,MZ,MZ,EFAVIRENZ,Aplasia cutis congenita;Foetal exposure during pregnancy,127428941,DE,,,,,,,,,127428941,1,Antiretroviral therapy
12742915,127429151,1,I,,20160909,20160914,20160914,EXP,,GB-MYLANLABS-2016M1039067,MYLAN,POST FA. PELLAGRA: A RARE COMPLICATION OF ISONIAZID THERAPY. INT-J-TUBERC-LUNG-DIS 2016;20(8):1136.,,,,,Y,,,20160914,,MD,GB,GB,EFAVIRENZ,Drug interaction;Nicotinic acid deficiency,127429151,HO,,,127429151,1,201510,,,,127429151,1,Tuberculosis
12744141,127441411,1,I,20150716,20160804,20160914,20160914,EXP,,ZA-GILEAD-2016-0229663,GILEAD,,34,YR,A,M,Y,44,KG,20160914,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Acute kidney injury;Gastroenteritis,127441411,HO,,,127441411,1,20100220,,,,127441411,1,HIV infection
12744704,127447042,2,F,,20160916,20160915,20160927,EXP,,ES-CIPLA LTD.-2016ES18271,CIPLA,"ESCOBAR-VILLALBA A, SAINZ DE LA MAZA S, PEREZ TORRE P, GALAN JC, RODRIGUEZ-DOMINGUEZ M, MONREAL LAGUILLO E, ET AL. ACUTE MYELITIS BY HUMAN HERPES VIRUS 7 IN AN HIV-INFECTED PATIENT. JOURNAL OF CLINICAL VIROLOGY. 2016;77:63 TO 65",,,,,Y,,,20160927,,OT,ES,ES,Efavirenz,Myelitis transverse,127447042,HO,,,,,,,,,127447042,1,HIV infection
12744899,127448991,1,I,,20160905,20160915,20160915,EXP,,US-HETERO LABS LTD-1057336,HETERO,,54,YR,,F,Y,,,20160915,,MD,US,US,EFAVIRENZ,Familial periodic paralysis;Fanconi syndrome,127448991,OT,,,,,,,,,,,
12747472,127474721,1,I,20150129,20160804,20160915,20160915,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069242,BRISTOL MYERS SQUIBB,,43,YR,,F,Y,,,20160915,,OT,ZA,ZA,"EFAVIRENZ;EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",Gamma-glutamyltransferase increased,127474721,OT,,,127474721,1,20110825,20150209,,,127474721,1,HIV infection
12747764,127477641,1,I,,20160909,20160915,20160915,EXP,,US-BMSGILMSD-2016-0233181,GILEAD,,51,YR,A,F,Y,,,20160915,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Fall;Pneumocystis jirovecii pneumonia,127477641,HO,,,,,,,,,127477641,1,HIV infection
12749672,127496721,1,I,20160720,20160912,20160916,20160916,EXP,,CI-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076201,BRISTOL MYERS SQUIBB,,37,YR,,F,Y,37,KG,20160916,,OT,CI,CI,EFAVIRENZ,Hypersomnia;Ulcer,127496721,HO,,,,,,,,,127496721,1,HIV infection
12751409,127514091,1,I,20141127,20160905,20160915,20160915,EXP,,ZA-GILEAD-2016-0232503,GILEAD,,51,YR,A,M,Y,55,KG,20160915,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Gastroenteritis;Meningitis cryptococcal,127514091,OT,,,127514091,1,20141023,,,,127514091,1,HIV infection
12753032,127530321,1,I,20150606,20160905,20160915,20160915,EXP,,ZA-GILEAD-2016-0233575,GILEAD,,26,YR,A,M,Y,,,20160915,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Mental disorder,127530321,HO,,,127530321,1,20150617,20150606,,,127530321,1,Antiretroviral therapy
12754282,127542821,1,I,20150919,20160804,20160915,20160915,EXP,,ZA-GILEAD-2016-0229601,GILEAD,,53,YR,A,M,Y,42.5,KG,20160915,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Gamma-glutamyltransferase increased;Pulmonary tuberculosis,127542821,OT,,,127542821,1,20131204,,,,127542821,1,HIV infection
12754486,127544861,1,I,20140804,20160905,20160915,20160915,EXP,,ZA-GILEAD-2016-0232384,GILEAD,,56,YR,A,F,Y,47.6,KG,20160915,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Asthenia;Cough;Pyrexia;Tuberculosis,127544861,HO,,,127544861,1,20131101,,,,127544861,1,HIV infection
12754541,127545411,1,I,20160211,20160905,20160915,20160915,EXP,,ZA-GILEAD-2016-0232774,GILEAD,,45,YR,A,F,Y,149,KG,20160915,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Anaemia;Extrapulmonary tuberculosis,127545411,HO,,,127545411,1,20150414,,,,127545411,1,HIV infection
12754707,127547071,1,I,20160618,20160905,20160915,20160915,EXP,,ZA-GILEAD-2016-0232496,GILEAD,,42,YR,A,M,Y,,,20160915,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Immune reconstitution inflammatory syndrome associated tuberculosis,127547071,DE,,,127547071,1,20160523,,,,127547071,1,HIV infection
12754910,127549101,1,I,20150817,20160905,20160916,20160916,EXP,,ZA-GILEAD-2016-0233288,GILEAD,,57,YR,A,F,Y,,,20160916,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Cervix carcinoma,127549101,OT,,,127549101,1,20130701,,,,127549101,1,HIV infection
12754968,127549681,1,I,20130724,20160905,20160916,20160916,EXP,,ZA-GILEAD-2016-0233276,GILEAD,,59,YR,A,M,Y,69,KG,20160916,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Cerebrovascular accident,127549681,OT,,,127549681,2,20130705,,,,127549681,1,HIV infection
12754978,127549781,1,I,20160322,20160905,20160916,20160916,EXP,,ZA-GILEAD-2016-0233259,GILEAD,,51,YR,A,F,Y,77.7,KG,20160916,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Type 2 diabetes mellitus,127549781,HO,,,127549781,1,20121115,,,,127549781,1,HIV infection
12755049,127550491,1,I,20121010,20160905,20160916,20160916,EXP,,ZA-GILEAD-2016-0233253,GILEAD,,38,YR,A,F,Y,80.6,KG,20160916,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Asthma,127550491,HO,,,127550491,1,20120411,,,,127550491,1,HIV infection
12755110,127551101,1,I,,20160830,20160916,20160916,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-072085,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20160916,,CN,US,US,SUSTIVA,Adverse event,,,,,,,,,,,127551101,1,HIV infection
12755111,127551111,1,I,20160503,20160512,20160916,20160916,EXP,,MZ-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-040754,BRISTOL MYERS SQUIBB,,18,YR,,F,Y,36,KG,20160916,,OT,MZ,MZ,EFAVIRENZ,Acute kidney injury;Anaemia;Arthralgia;Asthenia;Gait disturbance;Myalgia,127551111,OT,,,127551111,1,20160406,20160912,,,127551111,1,HIV infection
12755119,127551191,1,I,20151029,20160905,20160916,20160916,EXP,,ZA-GILEAD-2016-0233185,GILEAD,,56,YR,A,F,Y,52.7,KG,20160916,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Infection;Sepsis,127551191,HO,,,127551191,1,20150422,20150919,,,127551191,1,HIV infection
12755348,127553481,1,I,,20160907,20160916,20160916,EXP,,PHHY2016US127187,SANDOZ,"LAZENBY GB, MMEJE O, FISHER BM, WEINBERG A, AARON EK, KEATING M, ET AL.. ANTIRETROVIRAL RESISTANCE AND PREGNANCY CHARACTERISTICS OF WOMEN WITH PERINATAL AND NONPERINATAL HIV INFECTION.. INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY. 2016",,,,F,Y,,,20160916,,OT,US,US,EFAVIRENZ,Drug resistance;Maternal exposure during pregnancy,127553481,OT,,,,,,,,,127553481,1,Perinatal HIV infection
12756064,127560641,1,I,,20160912,20160916,20160916,EXP,,GB-MYLANLABS-2016M1039688,MYLAN,"GRIMES R, GILLEECE Y, APPLEBY T, STOCKWELL S, PINTO-SANDER N, SAHABANDU T, ET AL. A CASE OF HEREDITARY COPROPORPHYRIA PRECIPITATED BY EFAVIRENZ. AIDS 2016;30(13):2142-2143.",,,,,Y,,,20160916,,OT,GB,GB,EFAVIRENZ,Porphyria acute,127560641,OT,,,,,,,,,127560641,1,Antiretroviral therapy
12756258,127562581,1,I,20160301,20160905,20160916,20160916,EXP,,ZA-GILEAD-2016-0232746,GILEAD,,42,YR,A,F,Y,,,20160916,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Meningitis,127562581,HO,,,,,,,,,127562581,1,HIV infection
12756268,127562681,1,I,20140801,20160905,20160916,20160916,EXP,,ZA-GILEAD-2016-0233074,GILEAD,,,,,M,Y,41,KG,20160916,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Gastroenteritis,127562681,HO,,,127562681,1,20140731,,,,127562681,1,HIV infection
12756274,127562742,2,F,20150416,20160915,20160916,20160920,EXP,,ZA-GILEAD-2016-0233174,GILEAD,,27,YR,A,F,Y,54,KG,20160920,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Anaemia;Immune thrombocytopenic purpura;Thrombocytopenia,127562742,HO,,,,,,,,,127562742,1,Product used for unknown indication
12756285,127562851,1,I,20150319,20160905,20160916,20160916,EXP,,ZA-GILEAD-2016-0233068,GILEAD,,57,YR,A,F,Y,41.5,KG,20160916,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Malnutrition;Pulmonary tuberculosis,127562851,HO,,,127562851,1,20141031,20150326,,,127562851,1,HIV infection
12756301,127563011,1,I,20160523,20160905,20160916,20160916,EXP,,ZA-GILEAD-2016-0233014,GILEAD,,36,YR,A,F,Y,50,KG,20160916,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Pulmonary tuberculosis,127563011,OT,,,127563011,1,20150204,,,,127563011,1,HIV infection
12756352,127563521,1,I,20150309,20160907,20160916,20160916,EXP,,IL-GILEAD-2016-0232164,GILEAD,,66,YR,E,M,Y,105,KG,20160916,,MD,IL,IL,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Hypertension;Infection;Myocardial infarction;Nephropathy toxic;Proteinuria;Renal failure,127563521,OT,,,127563521,1,2004,201510,,,127563521,1,Product used for unknown indication
12756358,127563581,1,I,20130907,20160905,20160916,20160916,EXP,,ZA-GILEAD-2016-0232434,GILEAD,,73,YR,E,M,Y,74.9,KG,20160916,,MD,ZA,ZA,EFAVIRENZ;EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Cardiac failure congestive,127563581,OT,,,127563581,1,20130715,20130823,,,127563581,1,Retroviral infection
12756370,127563701,1,I,20130501,20160905,20160916,20160916,EXP,,ZA-GILEAD-2016-0232495,GILEAD,,46,YR,A,F,Y,,,20160916,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Confusional state;Peptic ulcer;Pneumonia;Pulmonary tuberculosis,127563701,DE,,,127563701,1,20120628,,,,127563701,1,HIV infection
12756374,127563741,1,I,20140816,20160905,20160916,20160916,EXP,,ZA-GILEAD-2016-0232491,GILEAD,,56,YR,A,F,Y,69.6,KG,20160916,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abdominal pain;Dysuria;Tachypnoea,127563741,HO,,,127563741,1,20130510,,,,127563741,1,HIV infection
12756376,127563761,1,I,20160323,20160905,20160916,20160916,EXP,,ZA-GILEAD-2016-0232780,GILEAD,,50,YR,A,F,Y,53.5,KG,20160916,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Tuberculosis,127563761,HO,,,127563761,1,20130809,,,,127563761,1,HIV infection
12756377,127563772,2,F,2013,20160912,20160916,20160923,EXP,,ZA-GILEAD-2016-0232808,GILEAD,,62,YR,A,M,Y,65.2,KG,20160923,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Joint swelling,127563772,HO,,,127563772,1,20141201,,,,127563772,1,HIV infection
12759469,127594691,1,I,20160228,20160905,20160919,20160919,EXP,,ZA-GILEAD-2016-0232917,GILEAD,,71,YR,E,F,Y,66.4,KG,20160919,,OT,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Gastroenteritis,127594691,HO,,,127594691,1,20140819,20160228,,,127594691,1,HIV infection
12760619,127606191,1,I,20131225,20160905,20160919,20160919,EXP,,ZA-GILEAD-2016-0232934,GILEAD,,26,YR,A,M,Y,60.7,KG,20160919,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Wrist fracture,127606191,OT,,,127606191,1,20121017,,,,127606191,1,HIV infection
12763410,127634102,2,F,20151207,20160922,20160920,20160928,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076105,BRISTOL MYERS SQUIBB,,32,YR,,F,Y,56,KG,20160928,,CN,CN,CN,EFAVIRENZ,Hepatic failure;Jaundice,127634102,OT,,,127634102,1,20150301,20151207,,,127634102,1,Acquired immunodeficiency syndrome
12764373,127643731,1,I,201607,20160914,20160920,20160920,EXP,,GB-GILEAD-2016-0233732,GILEAD,,56,YR,A,M,Y,,,20160920,,OT,GB,GB,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Death,127643731,OT,,,,,,,,,127643731,1,Product used for unknown indication
12764791,127647912,2,F,20160415,20160922,20160921,20160928,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076118,BRISTOL MYERS SQUIBB,,43,YR,,F,Y,64,KG,20160928,,CN,CN,CN,EFAVIRENZ,Hepatic failure;Jaundice,127647912,HO,,,127647912,1,20150901,,,,127647912,1,Acquired immunodeficiency syndrome
12764792,127647921,1,I,,20160912,20160921,20160921,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076797,BRISTOL MYERS SQUIBB,,25,YR,,M,Y,,,20160921,,OT,GB,GB,EFAVIRENZ,Porphyria acute,127647921,OT,,,,,,,,,127647921,1,HIV infection
12767460,127674601,1,I,20150416,20150420,20160921,20160921,EXP,,UG-GILEAD-2015-0150161,GILEAD,,45,YR,A,M,Y,52,KG,20160921,,MD,UG,UG,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Meningitis cryptococcal,127674601,DS,,,127674601,1,20150407,20150416,,,127674601,1,Kaposi's sarcoma AIDS related
12767669,127676692,2,F,,20160919,20160921,20160926,EXP,,MZ-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-075444,BRISTOL MYERS SQUIBB,,,,N,F,Y,1.48,KG,20160926,,OT,MZ,MZ,EFAVIRENZ,Aplasia cutis congenita;Fistula;Foetal exposure during pregnancy;Low birth weight baby,127676692,HO,,,,,,,,,127676692,1,Product used for unknown indication
12781130,127811301,1,I,2010,20160810,20160926,20160926,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-077942,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160926,,OT,CA,US,EFAVIRENZ,Drug resistance;Live birth;Maternal exposure during delivery;Product use issue,127811301,OT,,,,,,,,,127811301,1,Perinatal HIV infection
12781495,127814951,1,I,,20160915,20160926,20160926,EXP,,GR-GLAXOSMITHKLINE-GR2016GSK136367,GLAXOSMITHKLINE,"ROMANOU B, XILOMENOS G, BLIOZIOTIS I, GARGALIANOS-KAKOLIRIS P.. CHRONIC LYMPHOCYTIC LEUKEMIA IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME AND A HISTORY OF HODGKIN LYMPHOMA. HELLENIC ARCHIVES OF AIDS. 2015;1",53,YR,,M,Y,,,20160926,,MD,GR,GR,Efavirenz,Chronic lymphocytic leukaemia;Leukocytosis,127814951,OT,,,,,,,,,127814951,1,HIV infection
12781829,127818291,1,I,20131019,20160905,20160926,20160926,EXP,,ZA-GILEAD-2016-0233277,GILEAD,,48,YR,A,F,Y,81,KG,20160926,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Anaemia;Uterine leiomyoma,127818291,HO,,,127818291,1,20150715,,,,127818291,1,HIV infection
12783821,127838211,1,I,,20160915,20160927,20160927,EXP,,GR-VIIV HEALTHCARE LIMITED-GR2016GSK136367,VIIV,"ROMANOU B, XILOMENOS G, BLIOZIOTIS I, GARGALIANOS-KAKOLIRIS P.. CHRONIC LYMPHOCYTIC LEUKEMIA IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME AND A HISTORY OF HODGKIN LYMPHOMA. HELLENIC ARCHIVES OF AIDS. 2015;1",53,YR,,M,Y,,,20160927,,MD,GR,GR,Efavirenz,Chronic lymphocytic leukaemia;Leukocytosis,127838211,OT,,,,,,,,,127838211,1,HIV infection
12786757,127867571,1,I,,20160921,20160928,20160928,PER,,US-PFIZER INC-2016443142,PFIZER,,,,,M,Y,,,20160928,,OT,US,US,SUSTIVA,Drug hypersensitivity,,,,,,,,,,,,,
12786932,127869321,1,I,20160815,20160818,20160927,20160927,EXP,,MW-GILEAD-2016-0230079,GILEAD,,25,YR,A,F,Y,,,20160927,,MD,MW,MW,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Bacterial infection,127869321,DE,,,127869321,1,20140507,20160814,,,127869321,1,HIV infection
12787367,127873671,1,I,,20160916,20160928,20160928,EXP,,BR-HETERO LABS LTD-1057792,HETERO,,,,,F,Y,,,20160928,,OT,BR,BR,Efavirenz\ lamivudine \ Tenofovir  disoproxil fumarate,Congenital umbilical hernia;Foetal exposure during pregnancy,127873671,OT,,,127873671,1,20160302,20160818,,,127873671,1,HIV infection
12787620,127876201,1,I,,20160915,20160928,20160928,EXP,,CA-CIPLA LTD.-2016US18765,CIPLA,,,,,,Y,,,20160928,,OT,CN,CA,Tenofovir/Emtricitabine/Efavirenz,Renal failure;Sepsis,127876201,DE,,,,,,,,,127876201,1,HIV infection
12787658,127876581,1,I,,20160915,20160928,20160928,EXP,,CA-CIPLA LTD.-2016US18766,CIPLA,,,,,,Y,,,20160928,,OT,CN,CA,Tenofovir/Emtricitabine/Efavirenz,Pneumonia,127876581,DE,,,,,,,,,127876581,1,HIV infection
12789253,127892531,1,I,2013,20160907,20160928,20160928,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-077950,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160928,,OT,CA,US,"EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",Live birth;Maternal exposure during pregnancy,,,,,,,,,,,127892531,1,HIV infection
12789401,127894011,1,I,,20160922,20160928,20160928,EXP,,US-GILEAD-2016-0234937,GILEAD,,36,YR,A,M,Y,,,20160928,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Dizziness;Fatigue;Loss of consciousness,127894011,OT,,,127894011,1,,20160920,,,127894011,1,Product used for unknown indication
12789452,127894521,1,I,201606,20160920,20160928,20160928,EXP,,UG-GILEAD-2016-0234781,GILEAD,,37,YR,A,F,Y,66,KG,20160928,,MD,UG,UG,EFAVIRENZ,Abortion incomplete;Anaemia;Maternal exposure during pregnancy,127894521,HO,,,127894521,1,20130603,,,,127894521,1,HIV infection
12792737,127927371,1,I,,20160620,20160929,20160929,PER,,US-JAZZ-2016-US-011546,JAZZ,,,,,M,Y,,,20160929,,,US,US,Efavirenz,Blood pressure increased;Hunger;Thirst,,,,,127927371,1,201507,201507,,,127927371,1,Narcolepsy
12796543,127965431,1,I,2012,20160907,20160929,20160929,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-077951,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160929,,OT,CA,US,"EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",Live birth;Maternal exposure during pregnancy,,,,,,,,,,,127965431,1,HIV infection
12796547,127965471,1,I,20141110,20160905,20160929,20160929,EXP,,ZA-GILEAD-2016-0232398,GILEAD,,60,YR,A,F,Y,67,KG,20160929,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Cough;Malnutrition;Night sweats;Pleural effusion,127965471,OT,,,127965471,1,20130606,,,,127965471,1,HIV infection
12796591,127965911,1,I,,20160922,20160929,20160929,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-079766,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20160929,,CN,US,US,SUSTIVA,Dialysis,127965911,OT,,,,,,,,,127965911,1,HIV infection
12798946,127989461,1,I,20160822,20160825,20160930,20160930,EXP,,ZW-GILEAD-2016-0231062,GILEAD,,53,YR,A,F,Y,59,KG,20160930,,OT,ZW,ZW,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Anaemia;Creatinine renal clearance decreased,127989461,OT,,,127989461,1,20150120,20160615,,,127989461,1,HIV infection
12799647,127996471,1,I,201209,20160804,20160930,20160930,EXP,,ZA-GILEAD-2016-0229602,GILEAD,,35,YR,A,F,Y,,,20160930,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Blood pressure increased;Delivery;Maternal exposure during pregnancy;Normal newborn,127996471,HO,,,127996471,1,20130314,,,,127996471,1,HIV infection
3839792,38397925,5,F,20020710,20160824,20020918,20160825,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-12035572,BRISTOL MYERS SQUIBB,,0,DY,,F,Y,2.5,KG,20160825,,OT,US,US,EFAVIRENZ,Cleft palate;Foetal exposure during pregnancy,38397925,OT,,,38397925,1,20020218,20020114,,,38397925,1,Product used for unknown indication
3998234,39982343,3,F,20010114,20160824,20030915,20160824,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-12201240,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160824,,OT,US,US,SUSTIVA,Foetal exposure during pregnancy;Neural tube defect;Talipes,39982343,OT,,,39982343,1,200006,20001020,,,39982343,1,Product used for unknown indication
4175225,417522510,10,F,,20160824,20040723,20160825,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-12645404,BRISTOL MYERS SQUIBB,,1,DY,,M,Y,4.15,KG,20160825,,OT,CH,US,EFAVIRENZ,Arnold-Chiari malformation;Foetal exposure during pregnancy;Large for dates baby;Meningomyelocele;Premature baby,417522510,CA,,,417522510,2,20030310,20040219,,,417522510,1,Product used for unknown indication
6013552,60135523,3,F,200206,20160824,20060328,20160824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-13322532,BRISTOL MYERS SQUIBB,,,,,M,Y,2.6,KG,20160824,,MD,DE,DE,SUSTIVA,Dyspnoea;Foetal exposure during pregnancy;Group B streptococcus neonatal sepsis;Rotavirus infection,60135523,OT,,,60135523,1,200110,200110,,,60135523,1,Product used for unknown indication
6013572,60135723,3,F,1994,20160824,20060328,20160824,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-13309745,BRISTOL MYERS SQUIBB,,38,YR,,F,Y,56,KG,20160824,,MD,DE,DE,SUSTIVA,Abdominal pain upper;Asthenia;Caesarean section;Diabetes mellitus;Diarrhoea;Drug ineffective;Flatulence;Herpes zoster;Lipodystrophy acquired;Live birth;Myalgia;Oedema peripheral;Pancreatitis acute;Pneumocystis jirovecii pneumonia;Pregnancy;Premature delivery;Pruritus;Urticaria papular,60135723,OT,,,60135723,1,1999,200110,,,60135723,1,HIV infection
6073969,60739695,5,F,20050926,20160824,20060628,20160825,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-13421672,BRISTOL MYERS SQUIBB,,0,YR,,M,Y,2.76,KG,20160825,,MD,US,US,EFAVIRENZ,Eyelid ptosis;Foetal exposure during pregnancy;Hemiparesis;Hydrocele;Ultrasound scan abnormal,60739695,OT,,,60739695,2,20050916,20060122,,,60739695,1,Product used for unknown indication
6260112,62601125,5,F,,20160824,20070313,20160825,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-13709290,BRISTOL MYERS SQUIBB,,1,DY,,,Y,,,20160825,,OT,IT,IT,EFAVIRENZ,Foetal exposure during pregnancy;Talipes,62601125,OT,,,,,,,,,62601125,1,HIV infection
6356516,635651610,10,F,20070702,20160824,20070713,20160825,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-13837919,BRISTOL MYERS SQUIBB,,0,YR,,F,Y,1.11,KG,20160825,,CN,US,US,EFAVIRENZ,Breech presentation;Dandy-Walker syndrome;Foetal exposure during pregnancy;Foetal growth restriction;Foetal malformation;Umbilical cord around neck,635651610,OT,,,635651610,1,20070201,20070201,,,635651610,1,Product used for unknown indication
6431218,643121811,11,F,20080108,20160830,20071001,20160902,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-13921481,BRISTOL MYERS SQUIBB,,,,N,F,Y,2.95,KG,20160902,,OT,ZA,US,EFAVIRENZ,Amniotic band syndrome;Anophthalmos;Cleft lip and palate;Foetal exposure during pregnancy;Neural tube defect;Premature baby,643121811,OT,,,643121811,1,20070627,20070627,,,643121811,1,Product used for unknown indication
6455930,64559302,2,F,,20160824,20071031,20160825,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-13376918,BRISTOL MYERS SQUIBB,,1,DY,,M,Y,,,20160825,,MD,US,US,EFAVIRENZ,Chordee;Foetal exposure during pregnancy;Hypospadias,64559302,OT,,,,,,,,,64559302,1,Product used for unknown indication
6532801,65328013,3,F,2007,20160824,20080123,20160824,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-14046544,BRISTOL MYERS SQUIBB,,38,YR,,F,Y,,,20160824,,OT,FR,FR,SUSTIVA,Caesarean section;HELLP syndrome;Mania;Maternal exposure during pregnancy;Pre-eclampsia;Premature delivery;Twin pregnancy,65328013,OT,,,65328013,1,20070328,20070808,,,65328013,1,Antiretroviral therapy
6797602,67976027,7,F,20070611,20160822,20081028,20160822,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-14332951,BRISTOL MYERS SQUIBB,,34,YR,,F,Y,92,KG,20160822,,MD,FR,FR,SUSTIVA,Abortion induced;Oligohydramnios;Pregnancy on contraceptive,67976027,OT,,,67976027,1,20070217,20070703,,,67976027,1,HIV infection
6806942,680694210,10,F,20080422,20160824,20081110,20160824,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-14017800,BRISTOL MYERS SQUIBB,,32,YR,,F,Y,68,KG,20160824,,CN,GB,FR,SUSTIVA,Abortion induced;Maternal exposure during pregnancy,680694210,OT,,,680694210,1,20051201,20071211,,,680694210,1,Antiretroviral therapy
7117171,71171719,9,F,,20160914,20090917,20160922,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-14780902,BRISTOL MYERS SQUIBB,,52,YR,,M,Y,,,20160922,,CN,US,CA,SUSTIVA,Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Progressive external ophthalmoplegia,71171719,OT,,,71171719,10,200802,,,,71171719,1,HIV infection
7302622,730262226,26,F,,20160914,20100302,20160923,EXP,,CA-MERCK-0907CAN00093,MERCK,,52,YR,,M,Y,,,20160923,,CN,US,CA,SUSTIVA,Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Progressive external ophthalmoplegia,730262226,OT,,,730262226,5,200802,,,,730262226,1,HIV infection
7326581,73265815,5,F,,20160908,20100321,20160909,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-15024797,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160909,,OT,US,US,SUSTIVA,Foetal exposure during pregnancy;Gastroschisis,73265815,OT,,,,,,,,,73265815,1,Product used for unknown indication
7328578,73285784,4,F,,20160621,20100323,20160705,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-15029879,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160705,,OT,US,US,EFAVIRENZ,Foetal exposure during pregnancy;Plagiocephaly,73285784,CA,,,,,,,,,73285784,1,Product used for unknown indication
7370455,73704554,4,F,20091130,20160819,20100429,20160826,EXP,,US-GILEAD-2010-0028688,GILEAD,,40,YR,A,F,Y,,,20160826,,OT,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abortion induced;Amniocentesis abnormal;Maternal exposure during pregnancy,73704554,OT,,,73704554,1,20091201,20091101,,,73704554,1,HIV infection
7370594,73705944,4,F,20100311,20160822,20100429,20160825,EXP,,US-GILEAD-2010-0028690,GILEAD,,,,,,Y,,,20160825,,OT,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Foetal exposure during pregnancy;Klinefelter's syndrome,73705944,OT,,,73705944,1,20091201,20100327,,,73705944,1,HIV infection
7371076,73710763,3,F,20100317,20160822,20100429,20160830,EXP,,US-GILEAD-2010-0028676,GILEAD,,36,YR,A,F,Y,,,20160830,,OT,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abortion spontaneous;Intrauterine infection;Maternal exposure during pregnancy,73710763,OT,,,73710763,1,20100219,20100201,,,73710763,1,HIV infection
7408389,74083893,3,F,201004,20160824,20100603,20160824,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-15120728,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160824,,CN,FR,FR,SUSTIVA,Foetal exposure during pregnancy;Hydrocephalus,74083893,OT,,,74083893,1,20070817,20091202,,,74083893,1,Product used for unknown indication
7408392,74083925,5,F,20100421,20160824,20100603,20160824,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-15126741,BRISTOL MYERS SQUIBB,,31,YR,,F,Y,,,20160824,,CN,FR,FR,SUSTIVA,Abortion induced;Bartholinitis;Maternal exposure during pregnancy;Pyelonephritis,74083925,OT,,,74083925,1,20070817,20091202,,,74083925,1,HIV infection
7570982,75709828,8,F,2009,20160822,20100902,20160823,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-15256449,BRISTOL MYERS SQUIBB,,0,YR,,F,Y,6.76,KG,20160823,,CN,US,DE,SUSTIVA,Cerebral palsy;Congenital hydrocephalus;Foetal exposure during pregnancy;Intestinal perforation;Intraventricular haemorrhage;Microcephaly;Neonatal respiratory distress syndrome;Patent ductus arteriosus;Peritonitis;Premature baby;Retinopathy of prematurity;Strabismus,75709828,OT,,,75709828,4,,20090613,,,75709828,1,Product used for unknown indication
8745670,87456706,6,F,,20160825,20120826,20160826,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-16898553,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160826,,CN,GB,GB,SUSTIVA,Foetal exposure during pregnancy;Turner's syndrome,87456706,OT,,,87456706,1,2011,,,,87456706,1,Product used for unknown indication
8784344,87843444,4,F,,20160831,20120913,20160902,EXP,,GB-GILEAD-2012-0060487,GILEAD,,,,,F,Y,,,20160902,,CN,GB,GB,SUSTIVA,Foetal exposure during pregnancy;Turner's syndrome,87843444,CA,,,87843444,1,2011,,,,87843444,1,Product used for unknown indication
9060495,90604953,3,F,,20160825,20130212,20160826,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-17351255,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160826,,CN,FR,FR,SUSTIVA,Bronchopulmonary dysplasia;Congenital anomaly of adrenal gland;Dysmorphism;Foetal exposure during pregnancy;Hydrocephalus,90604953,OT,,,,,,,,,90604953,1,Product used for unknown indication
9139008,91390083,3,F,,20160825,20130305,20160826,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-17431057,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160826,,MD,PT,PT,EFAVIRENZ,Foetal exposure during pregnancy;Foetal malformation,91390083,OT,,,91390083,1,201202,,,,91390083,1,Product used for unknown indication
9277071,92770714,4,F,199810,20160711,20130507,20160713,EXP,,US-009507513-1305USA001538,MERCK,,,,,M,Y,83.45,KG,20160713,,MD,US,US,SUSTIVA,Agitation;Amnesia;Anxiety;Blood testosterone decreased;Cognitive disorder;Depression;Disturbance in attention;Erectile dysfunction;Facial wasting;Fatigue;Homeless;Judgement impaired;Major depression;Memory impairment;Nervous system disorder;Post-traumatic stress disorder;Rash;Sexual dysfunction;Suicidal ideation;Swelling face,92770714,DS,,,92770714,1,19980128,20000721,,,92770714,1,Alopecia
9317994,93179942,2,F,,20160726,20130530,20160726,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-18919407,BRISTOL MYERS SQUIBB,,5,DEC,,F,Y,,,20160726,,OT,ZA,ZA,EFAVIRENZ,Mycosis fungoides,93179942,OT,,,93179942,1,201003,,,,93179942,1,Antiretroviral therapy
9349255,93492552,2,F,,20160712,20130614,20160714,EXP,,IN-BRISTOL-MYERS SQUIBB COMPANY-18979351,BRISTOL MYERS SQUIBB,,10,YR,,M,Y,,,20160714,,OT,IN,IN,EFAVIRENZ,Drug ineffective;Drug resistance,93492552,DE,,,93492552,1,2005,,,,93492552,1,Antiretroviral therapy
9361971,93619712,2,F,,20160721,20130621,20160721,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19030071,BRISTOL MYERS SQUIBB,,,,T,,Y,,,20160721,,CN,US,ZA,EFAVIRENZ,Lactic acidosis,93619712,OT,,,,,,,,,93619712,1,Antiretroviral therapy
9361978,93619782,2,F,,20160713,20130621,20160714,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19030121,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160714,,OT,ZA,ZA,EFAVIRENZ,Lactic acidosis,93619782,OT,,,,,,,,,93619782,1,Antiretroviral therapy
9365226,93652262,2,F,,20160721,20130624,20160721,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19030089,BRISTOL MYERS SQUIBB,,1,DEC,,,Y,,,20160721,,CN,US,ZA,EFAVIRENZ,Lactic acidosis,93652262,OT,,,,,,,,,93652262,1,Antiretroviral therapy
9365228,93652282,2,F,,20160713,20130624,20160714,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19030055,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160714,,CN,US,ZA,EFAVIRENZ,Lactic acidosis,93652282,OT,,,,,,,,,93652282,1,Antiretroviral therapy
9396656,93966562,2,F,,20160711,20130711,20160713,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19097500,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160713,,CN,US,ZA,EFAVIRENZ,Depression,93966562,OT,,,,,,,,,93966562,1,HIV infection
9462572,94625723,3,F,,20160711,20130816,20160713,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19180678,BRISTOL MYERS SQUIBB,,26,YR,,F,Y,,,20160713,,OT,ZA,ZA,EFAVIRENZ,Abortion spontaneous;Anaemia macrocytic;Hypertension;Maternal exposure during pregnancy;Renal tubular acidosis,94625723,OT,,,,,,,,,94625723,1,HIV infection
9462593,94625933,3,F,,20160711,20130816,20160713,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19180645,BRISTOL MYERS SQUIBB,,34,YR,,F,Y,,,20160713,,OT,ZA,ZA,EFAVIRENZ,Abortion induced;Maternal exposure during pregnancy,94625933,OT,,,,,,,,,94625933,1,HIV infection
9499125,94991253,3,F,,20160720,20130904,20160720,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19340579,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160720,,OT,ZA,ZA,EFAVIRENZ,Maternal exposure during pregnancy;Stillbirth;Twin pregnancy,94991253,OT,,,,,,,,,94991253,1,HIV infection
9499126,94991263,3,F,,20160720,20130904,20160720,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19340546,BRISTOL MYERS SQUIBB,,1,DY,,,Y,2.29,KG,20160720,,CN,US,ZA,EFAVIRENZ,Death neonatal;Foetal exposure during pregnancy;Low birth weight baby,94991263,OT,,,,,,,,,94991263,1,Product used for unknown indication
9499127,94991273,3,F,,20160720,20130904,20160720,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19340462,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160720,,CN,US,ZA,EFAVIRENZ,Foetal death;Maternal exposure during pregnancy;Twin pregnancy,94991273,DE,,,,,,,,,94991273,1,HIV infection
9499128,94991283,3,F,,20160720,20130904,20160720,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19340553,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160720,,OT,ZA,ZA,EFAVIRENZ,Maternal exposure during pregnancy;Stillbirth,94991283,OT,,,,,,,,,94991283,1,HIV infection
9499130,94991303,3,F,,20160720,20130904,20160720,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19340504,BRISTOL MYERS SQUIBB,,1,DY,,,Y,1.33,KG,20160720,,CN,US,ZA,EFAVIRENZ,Death neonatal;Foetal exposure during pregnancy;Premature baby,94991303,DE,,,,,,,,,94991303,1,Product used for unknown indication
9505157,95051575,5,F,20130523,20160905,20130906,20160912,EXP,,ZA-GILEAD-2013-0082749,GILEAD,,53,YR,A,F,Y,52,KG,20160912,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Acute kidney injury;Death;Gastroenteritis,95051575,OT,,,95051575,1,20130513,20130730,,,95051575,1,HIV infection
9538280,95382802,2,F,,20160712,20130920,20160714,EXP,,LS-BRISTOL-MYERS SQUIBB COMPANY-19219195,BRISTOL MYERS SQUIBB,,59,YR,,M,Y,,,20160714,,CN,US,LS,EFAVIRENZ,Drug resistance,95382802,OT,,,,,,,,,95382802,1,HIV infection
9607275,96072753,3,F,,20160725,20131009,20160725,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19532936,BRISTOL MYERS SQUIBB,"BARNARDT P, ET AL.. MANAGING AIDS-RELATED KAPOSI^S SARCOMA AND PREGNANCY. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE. 2013;14(2):87-8",24,YR,,F,Y,1.38,KG,20160725,,OT,ZA,ZA,EFAVIRENZ,Maternal exposure during pregnancy;Stillbirth,96072753,OT,,,96072753,1,2012,,,,96072753,1,HIV infection
9641700,96417002,2,F,,20160720,20131023,20160720,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19622133,BRISTOL MYERS SQUIBB,,50,YR,,M,Y,,,20160720,,CN,US,ZA,EFAVIRENZ,Drug ineffective;Injection site phlebitis,96417002,OT,,,,,,,,,96417002,1,HIV infection
9705354,97053543,3,F,,20160711,20131122,20160712,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-19809417,BRISTOL MYERS SQUIBB,,1,DY,,,Y,,,20160712,,CN,US,IT,EFAVIRENZ,Foetal exposure during pregnancy;Talipes,97053543,OT,,,,,,,,,97053543,1,Product used for unknown indication
9705451,97054513,3,F,,20160720,20131122,20160720,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-19838564,BRISTOL MYERS SQUIBB,,1,DY,,M,Y,,,20160720,,CN,IT,IT,EFAVIRENZ,Cryptorchism;Foetal exposure during pregnancy,97054513,CA,,,,,,,,,97054513,1,Product used for unknown indication
9720110,97201102,2,F,,20160720,20131128,20160720,EXP,,CI-BRISTOL-MYERS SQUIBB COMPANY-19859305,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160720,,CN,US,CI,EFAVIRENZ,Gastrointestinal disorder,97201102,DS,,,,,,,,,97201102,1,HIV infection
9720114,97201142,2,F,,20160720,20131128,20160720,EXP,,CI-BRISTOL-MYERS SQUIBB COMPANY-19859271,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160720,,CN,US,CI,EFAVIRENZ,Nephrotic syndrome;Renal failure,97201142,OT,,,,,,,,,97201142,1,HIV infection
9744065,97440652,2,F,,20160727,20131210,20160727,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19897594,BRISTOL MYERS SQUIBB,,,,A,F,Y,,,20160727,,OT,ZA,ZA,EFAVIRENZ,Erythema annulare;Photosensitivity reaction,97440652,HO,,,,,,,,,97440652,1,HIV infection
9744066,97440663,3,F,,20160715,20131210,20160715,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19897651,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160715,,CN,US,ZA,EFAVIRENZ,Erythema annulare;Maternal exposure during pregnancy;Photosensitivity reaction,97440663,HO,,,,,,,,,97440663,1,HIV infection
9746463,97464633,3,F,201310,20160905,20131211,20160909,EXP,,ZA-GILEAD-2013-0089120,GILEAD,,52,YR,A,M,Y,63,KG,20160909,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Dyspnoea,97464633,DE,,,97464633,1,20130605,,,,97464633,1,HIV infection
9746689,97466892,2,F,,20160714,20131211,20160714,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19897610,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160714,,CN,US,ZA,EFAVIRENZ,Erythema annulare;Photosensitivity reaction,97466892,HO,,,,,,,,,97466892,1,HIV infection
9746692,97466922,2,F,,20160714,20131211,20160714,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19897628,BRISTOL MYERS SQUIBB,,,,A,F,Y,,,20160714,,CN,US,ZA,EFAVIRENZ,Erythema annulare;Photosensitivity reaction,97466922,HO,,,,,,,,,97466922,1,HIV infection
9746710,97467102,2,F,,20160714,20131211,20160714,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-19897644,BRISTOL MYERS SQUIBB,,,,A,F,Y,,,20160714,,CN,US,ZA,EFAVIRENZ,Erythema annulare;Photosensitivity reaction,97467102,HO,,,,,,,,,97467102,1,HIV infection
9747500,97475003,3,F,,20160721,20131212,20160721,EXP,,CI-BRISTOL-MYERS SQUIBB COMPANY-19859917,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160721,,CN,US,CI,EFAVIRENZ,Delirium;Dizziness;Nightmare,97475003,OT,,,,,,,,,97475003,1,HIV infection
9755933,97559332,2,F,,20160722,20131213,20160722,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-19915149,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20160722,,OT,ES,ES,EFAVIRENZ,Drug interaction;Drug level decreased;Neurological symptom,97559332,OT,,,,,,,,,97559332,1,HIV infection
9756654,97566543,3,F,,20160722,20131213,20160722,EXP,,ET-BRISTOL-MYERS SQUIBB COMPANY-19886787,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160722,,OT,ET,ET,EFAVIRENZ,Encephalocele;Foetal exposure during pregnancy,97566543,OT,,,,,,,,,97566543,1,Product used for unknown indication
9788545,97885453,3,F,,20160722,20131230,20160722,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-19951789,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160722,,CN,US,TR,EFAVIRENZ,Osteonecrosis,97885453,OT,,,,,,,,,97885453,1,HIV infection
9886886,98868867,7,F,20121026,20160902,20140210,20160929,EXP,,UG-BRISTOL-MYERS SQUIBB COMPANY-17227166,BRISTOL MYERS SQUIBB,,34,YR,,F,Y,39,KG,20160929,,CN,US,UG,"EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",Burning sensation;Diarrhoea;Hypokalaemia;Hyponatraemia;Malaise;Muscular weakness;Neuropathy peripheral;Neutropenia;Pyrexia;Vomiting,98868867,OT,,,98868867,1,20121115,20131107,,,98868867,1,HIV infection
9964259,99642592,2,F,,20160711,20140305,20160714,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-20385860,BRISTOL MYERS SQUIBB,,,,,,Y,,,20160714,,CN,US,IT,EFAVIRENZ,Death,99642592,DE,,,,,,,,,99642592,1,HIV infection
9964461,99644613,3,F,,20160722,20140305,20160722,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-20339826,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20160722,,OT,FR,SN,EFAVIRENZ,Maternal exposure during pregnancy;Stillbirth,99644613,OT,,,,,,,,,99644613,1,HIV infection
